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Today it is well acknowledged that both nature and nurture play important roles in the
genesis of psychopathologies, including drug addiction. Increasing evidence suggests
that genetic factors contribute for at least 40–60% of the variation in liability to drug
dependence. Human genetic studies suggest that multiple genes of small effect, rather
than single genes, contribute to the genesis of behavioral psychopathologies. Therefore,
the use of inbred rat strains might provide a valuable tool to identify differences, linked
to genotype, important in liability to addiction and related disorders. In this regard, Lewis
and Fischer 344 inbred rats have been proposed as a model of genetic vulnerability
to drug addiction, given their innate differences in sensitivity to the reinforcing and
rewarding effects of drugs of abuse, as well their different responsiveness to stressful
stimuli. This review will provide evidence in support of this model for the study of
the genetic influence on addiction vulnerability, with particular emphasis on differences
in mesolimbic dopamine (DA) transmission, rewarding and emotional function. It will
be highlighted that Lewis and Fischer 344 rats differ not only in several indices of
DA transmission and adaptive changes following repeated drug exposure, but also
in hypothalamic-pituitary-adrenal (HPA) axis responsiveness, influencing not only the
ability of the individual to cope with stressful events, but also interfering with rewarding
and motivational processes, given the influence of corticosteroids on dopamine neuron
functionality. Further differences between the two strains, as impulsivity or anxiousness,
might contribute to their different proneness to addiction, and likely these features might
be linked to their different DA neurotransmission plasticity. Although differences in other
neurotransmitter systems might deserve further investigation, results from the reviewed
studies might open new vistas in understanding aberrant deviations in reward and
motivational functions.
Keywords: Lewis rats, Fischer 344 rats, reward, addiction, impulsivity, HPA axis
INTRODUCTION
Reward is an essential function for the survival of individuals and for species perpetuation. In
addition, it is a fundamental concept for discussions on drug abuse and addiction. Thus, in most
theories of addiction altered sensitivity to either drug-reward, or to reward in general, contributes to
or results from drug taking behavior (Di Chiara, 1998; Everitt et al., 2001; Robinson and Berridge,
2001, 2008; Di Chiara et al., 2004; Koob, 2006, 2013; Everitt and Robbins, 2013; Wise and Koob,
2014). This comes from the fact that drugs of abuse interact directly with the reward system, whose
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normal purpose is to provide the organism with the ability
to recognize biologically relevant events occurring in the
environment.
It has been clearly shown that both nature and nurture
model the individual phenotype contributing both to successful
adaptation to different environmental events but also playing
important roles in the genesis of psychopathologies, included
drug addiction, as demonstrated by family, twin, and adoption
studies (Crabbe, 2002; Tsuang et al., 2004). While the role
of genetic background in the onset of psychopathologies is
well recognized, it remains difficult to find genes for these
disorders. The main reason for this is the complex interaction
of multiple genes of small effects with a variety of environmental
factors. Thus, gene-environment interaction might provide one
explanation for inconsistent findings in genetic association
studies between genetic markers and mental disorders, as well
as variability in heritability estimates for the same disorders
(Kendler and Eaves, 1986; Ottman, 1996; Yang and Khoury, 1997;
Rutter and Silberg, 2002; Dick et al., 2015).
Among the different approaches available to investigate
genetic contribution to behavioral disorders, the use of genetic
animal models has great potential as demonstrated by the
advancement of our knowledge especially in the field of
substance addiction (Crabbe, 2002). Compared to human
genetic studies animal models offer the advantage of studying
a particular behavioral phenotype in inbred strains under
controlled experimental conditions through manipulations that,
for ethical reasons, are not possible in humans. Needless to say
animal models cannot reproduce the complex human condition
(Stephens et al., 2010), but nonetheless might provide new
insights guiding future human genetic studies.
When reasoning about reward mechanisms, and thus about
addiction, the focus of discussions has been the dopamine (DA)
system and in particular the mesolimbic DA system. Once it was
true that all roads led to Rome, recently it has been said that all
roads lead to dopamine, since most of the scientific literature
recognizes that the major reward neurotransmitter pathway in
the brain is indeed the dopamine system (Blum et al., 2012).
For this reason the majority of studies aimed at understanding
the molecular processes leading to dependence have been mainly
focused on this system. This has been our aim too, trying to link
genetic vulnerability to drug addiction to innate differences inDA
system functionality and plasticity.
The present review will present evidence pointing to the
validity, or suitability, of the Fischer 344 (F344) and Lewis
(LEW) model as an investigative tool for understanding how
genetic vulnerability is translated in neurochemical terms,
thus providing new targets for genetic human studies. First,
results from behavioral studies will be presented, highlighting
differences in sensitivity to the rewarding and reinforcing
properties of different drugs of abuse. Then, evidence concerning
DA transmission functionality, by using in vitro and in vivo
techniques, will provide a likely explanation for the previously
reported behavioral differences between strains. Since one of
the major differences between these strains is their different
sensitivity to stress, differences in their hypothalamic-pituitary-
adrenal (HPA) axis activity will be shown that might help
to explain their different vulnerability to addiction, given the
known ability of this system to interfere with rewarding and
motivational processes. Moreover, differences between strains in
other neurotransmitter systems, structural plasticity, and gene
expression will be presented to further help in understanding the
neurobiological basis of genetic vulnerability to drug addiction.
When available, findings from genetic human studies, pointing
to genes for proteins found to be differentially expressed in these
strains, will be discussed to further strengthen the validity of this
model, and increase our knowledge on genetic contribution to
addiction.
BEHAVIORAL STUDIES
Early evidence of differential sensitivity of F344 and LEW strains
to drugs of abuse was reported in 1988 by Suzuki et al. showing
that ethanol serves as a strong positive reinforcer for LEW but
as a weak reinforcer for F344 rats (Suzuki et al., 1988a) and
that preference for morphine and codeine admixed food was
higher in LEW as compared with F344 strain (Suzuki et al.,
1988b). Behavioral studies on the effects of chronic morphine
administration showed that LEW rats display a greater amount,
but also a greater rate of reduction, of stupor across the 7 days of
morphine treatment and show larger signs of opiate withdrawal
following naloxone injection at the end of morphine treatment
as compared with F344 strain (Mayo-Michelson and Young,
1992). However, F344 rats are highly susceptible to dependence
on benzodiazepines (Suzuki et al., 1992), although severity of
withdrawal signs following chronic pentobarbital is greater in
LEW than in F344 rats (Suzuki et al., 1987). In this section several
findings will be presented pointing to the LEW strain as more
sensitive, compared with F344, to the rewarding and reinforcing
properties of drugs of abuse.
Conditioned Place Preference Studies
Place conditioning is a procedure commonly used to measure
the motivational effects of rewarding and aversive stimuli in
laboratory rodents (Tzschentke, 1998, 2007; Bardo and Bevins,
2000; Huston et al., 2013). This paradigm is based on principles
of Pavlovian conditioning, where an unconditioned stimulus
(US, for example a drug) is repeatedly paired with a neutral
environment characterized by distinctive cues (visual, tactile,
and eventually, olfactory). By repeated pairing, the paired
environment acquires motivational properties and becomes a
conditioned stimulus (CS), approached or avoided depending
on the nature of the US. Using this paradigm it has been
demonstrated that most drugs of abuse induce conditioned
place preference (CPP) reflecting their rewarding properties (see
Tzschentke, 2007 for an extensive review).
Few CPP studies have been performed on F344 and LEW
rats but most of them have demonstrated that morphine, heroin,
cocaine, and nicotine are more rewarding in LEW than in F344
strain (Guitart et al., 1992; Kosten et al., 1994; Horan et al., 1997;
Philibin et al., 2005; Grakalic et al., 2006; Cadoni et al., 2015),
with the only exception being that of amphetamine CPP where
F344 rats display preference for the drug paired compartment
while LEW do not (Stöhr et al., 1998). While contrasting results
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with the above findings on morphine rewarding effects (Davis
et al., 2007) might be explained by the nature, biased vs. unbiased,
of the CPP procedure utilized, it should be underlined that
different results might be obtained depending on the drug dose
utilized (Kosten et al., 1994). This fact seems to be consistent
with different effects of drugs of abuse on mesolimbic DA
transmission depending on drug dose (Cadoni and Di Chiara,
2007). It seems that drugs stimulating DA transmission in
the nucleus accumbens (NAc) shell to a greater extent, or
showing a preferential stimulation of DA transmission in the shell
compared with the core of NAc, induce a higher preference for
the compartment previously paired with the drug (see Cadoni
and Di Chiara, 2007 for a discussion). This is consistent with the
role of DA in theNAc shell in incentive learning (Fenu et al., 2006;
Spina et al., 2006).
However, when using the CPP paradigm for testing drug
reward it should be kept in mind that results from these
studies might be affected by adaptive changes in mesolimbic
DA transmission, occurring after repeated drug exposure during
conditioning (e.g., biochemical sensitization), that might be
different in the two strains (Cadoni et al., 2015). While
sensitization of DA and GLU transmission in the NAc core might
delay extinction of CPP, given the role played by DA and GLU
transmission in this area in drug reward memory (Wang et al.,
2008; Li et al., 2011; Kobrin et al., 2015), sensitization of DA
transmission in the NAc shell might increase the incentive value
of the drug paired compartment (Bossert et al., 2007, 2012; Ito
and Hayen, 2011) leading to increased CPP.
Moreover, the different hypothalamic-pituitary-
adrenocortical (HPA) axis responsiveness of the two strains
might play also a role in the effects of psychostimulants in CPP
paradigm. Thus, it is known that the HPA axis has a role in the
behavioral and biochemical effects of psychostimulants (Rivet
et al., 1989; Cole et al., 1990) and that stress cross-sensitizes with
psychostimulants (Deroche et al., 1995; Kalivas and Stewart,
1995; Prasad et al., 1995; Rougé-Pont et al., 1995; Cadoni et al.,
2003). This cross-sensitization has been reported to be associated
with an increased DA transmission in the NAc core (Cadoni
et al., 2003), as observed in the case of drug-induced sensitization
(Cadoni and Di Chiara, 1999; Cadoni et al., 2000; Vanderschuren
and Kalivas, 2000). Thus, differences between strains in HPA axis
reactivity to psychostimulants might play a role in differences
found in psychostimulant CPP studies. It might be hypothesized
that greater amphetamine CPP observed in F344 vs. LEW strain
is related to their higher HPA axis reactivity to the same drug,
through an influence on DA transmission in the NAc core.
Operant Self-Administration Studies
In addition to non-operant self-administration studies reported
above, operant self-administration (SA) studies have provided
further evidence of the vulnerability of LEW rats to the
reinforcing properties of several drugs of abuse.
A wide range of drug self-administration techniques has
been developed to model specific aspects of addiction (Panlilio
and Goldberg, 2007). Thus, while fixed ratio (FR) schedule of
responding is a measure of the reinforcing properties of the
drug, change in the effort required to obtain the reinforcer gives
us a measure of the animal’s motivation to work for obtaining
that reinforcer, thus giving us more insight into the process of
transition to addiction. In this regard, the progressive ratio (PR)
schedule, utilized in several SA studies, is intended to better
characterize the individual vulnerability of the animal based on
the assumption that the greater is the animal’s need for the drug
the greater will be the effort the animal will put in to obtain the
drug.
Another aspect of the procedure that has been used to mimic
better the human condition of transition from casual use to
addiction is the length of the session, as extended access (6 h
or more) to the drug could model the ideal condition to unveil
an escalation of drug intake suggestive of a development of
addiction. By the use of manipulations of the SA conditions it
is also possible to study the vulnerability of the individual to
relapse, thus mimicking one of the more challenging aspects
of drug addiction, through testing the ability of stress, drug-
conditioned cues or the drug itself to reinstate drug seeking and
taking behavior. To date, several SA studies have been performed
on LEW and F344 rats and most of them point to the LEW strain
as the vulnerable one or the “addiction prone” one.
Previous studies showed that LEW rats are more sensitive to
the reinforcing properties of ethanol. It has been demonstrated
that not only under FR1 but also under different FR schedules
of responding (1, 2, 4, 8, and 16), and using different ethanol
concentrations, LEW strain shows higher rates of responding,
greater ethanol intake, and higher blood ethanol levels compared
with F344 (George, 1987; Suzuki et al., 1988a).
With regards to opiates SA studies, LEW rats have been
reported to maintain higher rates of lever pressing and to
consume larger amounts of etonitazene, as compared with
F344 rats, in a operant self-administration paradigm where the
schedule of responding was increased from FR-1 up to FR-8,
thus demonstrating differences in opioid reinforcement between
strains (Suzuki et al., 1992). LEW rats acquire SA behavior faster,
show higher rate of responding for morphine and heroin and
show faster adaptation to the switching of the ratio schedule
of responding for heroin (Ambrosio et al., 1995; Martín et al.,
1999, 2003; Sánchez-Cardoso et al., 2007; Di Chiara et al., 2013),
irrespective of the dose used (García-Lecumberri et al., 2011), and
reach higher breaking points in PR schedule conditions (Martín
et al., 1999, 2003; García-Lecumberri et al., 2011; Di Chiara
et al., 2013). LEW rats show also shorter inter-response lever
presses in variable interval schedule of responding (Martín et al.,
2003), thus suggesting higher motivation and more compulsive
behavior of the LEW strain in drug taking.
A striking demonstration of the greater vulnerability of LEW
strain to addiction has been provided by the study of Picetti
et al. (2012) who, using an extended access (18 h/day) paradigm
that allowed the animal to choose between doses, showed that in
these conditions LEW rats escalate their heroin intake overtime
while F344 rats do not, thus mimicking the human condition of
heroin addiction. Moreover, they demonstrated LEW preference
for the higher and F344 preference for the lower doses of heroin,
most likely due to the differences in basal opioidergic tone in
the two strains and/or to differences in density and functionality
of µ opioid receptors (MORs) in the two strains after opiate
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self-administration (Sánchez-Cardoso et al., 2007; Picetti et al.,
2012).
Other studies investigating differences between strains in
cocaine SA, have reported some conflicting results. It has been
reported that LEW rats acquire cocaine SA faster and at lower
doses under a FR1 during 2 or 6 h/daily sessions, with no
differences in BP between strains in PR schedules (Kosten et al.,
1997; Freeman et al., 2009). Conversely, F344 rats have been
reported to self-administer more cocaine than LEW or SD rats
under both fixed and progressive ratio schedule of responding
(Kosten et al., 2007; Freeman et al., 2009) with more ineffective
lever presses observed in F344 rats, a possible measure of craving.
A more recent study by Picetti et al. (2010) provided a possible
explanation for these discrepancies by using an extended access
paradigm (18 h/day) allowing animals a dose choice. The results
obtained showed the clear preference of LEW rats for the two
higher doses and a high percentage of animals (35%) escalating
to the highest unit dose and increasing their total amount of
cocaine intake over days. Notably, while LEW rats started by
self-administering less cocaine than F344 rats, they escalated
their cocaine intake overtime, while F344 rats maintained a
constant intake across the exposure period, thereby agreeing
with a study that used a very different protocol (Freeman et al.,
2009).
There is limited evidence regarding SA of other
psychostimulants. Kruzich and Xi (2006b) showed that, in
a limited access (2 h) condition and under FR1 schedule of
responding, LEW rats display greater responding and higher
methamphetamine intake, and emit more ineffective responses
than F344 rats.
In another study, comparing 12 different inbred rat strains,
LEW rats acquired SA faster and showed higher rate of
responding during amphetamine SA than F344 rats, using
different FR schedules of responding (FR1 to FR5), even when
the dose was increased, but no difference was observed during
extinction or reinstatement by amphetamine priming (Meyer
et al., 2010).
An interesting study by Meyer and Bardo (2015) provided
evidence of the effects of rearing conditions on amphetamine
SA. When F344 and LEW rats are reared in social conditions
(i.e., housed in groups without objects) LEW rats show higher
amphetamine SA rate of responding, while these differences were
not detected in enriched (i.e., housed in groups with objects)
and isolated conditions, with enrichment buffering against SA,
and isolation increasing SA in both strains. These results, while
likely due to the different HPA activity of these strains, posit a
fundamental concern in experimental research due to differences
in breeding sources and different housing conditions used among
research groups.
LEW rats are highly sensitive to nicotine reinforcement
compared with F344, as previously suggested by CPP studies.
While, Shoaib et al. (1997) found that neither LEW nor F344
rats acquire nicotine SA, following studies (Brower et al.,
2002; Sharp et al., 2011), using an unlimited (23 h) as well
as a limited (2 h) access paradigm to nicotine and low doses
of nicotine (0.03mg/kg), showed that LEW, but not F344
rats, acquire and maintain nicotine SA at different FR (1–4)
schedules of responding and increase responses to increased
effort requirements or decreasing drug reinforcement (dose).
Moreover, a comparison of the reinforcing effects of nicotine
in 6 inbred rat strains showed that LEW rats were the most
sensitive while F344 rats were the least sensitive among the strains
utilized (Chen et al., 2012). Also noteworthy is the finding from
the same study about heritability of nicotine intake (0.64), which
was very similar to that obtained in human studies (0.33–0.71)
(Kendler et al., 1999; Maes et al., 2004; Vink et al., 2005; Ray et al.,
2007).
Characterization of a phenotype vulnerable to addiction
implies testing of reinstatement of drug seeking and taking
behavior by different stimuli. This is usually performed in the SA
paradigm after extinction training or sometimes after a period of
forced abstinence (Fuchs et al., 2006; Reichel and Bevins, 2009;
Millan et al., 2011).
Extinction is the reduction in drug seeking when the operant
behavior is not reinforced by the delivery of the drug anymore.
Few studies have evaluated extinction after psychostimulant and
opiate SA in F344 and LEW strains. After morphine SA either
a greater increase in responding in F344 than LEW rats or
no differences between strains were observed (Ambrosio et al.,
1995; Sánchez-Cardoso et al., 2007; Di Chiara et al., 2013).
Extinction of cocaine SA showed no differences between strains
(Miguéns et al., 2013) or greater responding during the 1st
session in F344 rats and higher responding during the 2nd and
the last session of extinction in LEW rats (Kruzich and Xi,
2006a). Followingmethamphetamine SA Kruzich and Xi (2006b)
found greater responding during the 1st session of extinction
in F344 compared with LEW rats, but F344 rats also showed
increased responding on the inactive lever. However, it should be
considered that extinction is an active learning process that might
be affected by several factors other than the animal’s motivation
for drug seeking and more importantly does not actually mimic
the human condition of abstinence thus lacking face validity
(Sanchis-Segura and Spanagel, 2006). Moreover, there is evidence
that extinction can ameliorate or reverse the neuroadaptations
produced by chronic drug SA and/or by spontaneous abstinence
(Millan et al., 2011).
In spite of several studies on morphine SA in F344 and LEW
rats, only one study has investigated differences in reinstatement
of opiate SA after extinction training (Di Chiara et al., 2013).
This showed that LEW rats are more vulnerable than F344 rats
to heroin priming reinstatement but not to drug conditioned
cue-induced reinstatement, thus in agreement with a previous
CPP study (Cadoni et al., 2015). In psychostimulant SA studies
LEW rats showed higher rate of responding following cocaine
or methamphetamine priming injections compared with F344
rats (Kruzich and Xi, 2006a,b; Miguéns et al., 2013). Table 1
summarizes the above results.
It should be emphasized that in food operant SA studies no
difference between strains has been detected (Martín et al., 1999;
Wilhelm and Mitchell, 2009; Sharp et al., 2011; Chen et al.,
2012, but see also Christensen et al., 2009) thus excluding that
differences observed between strains in drug SA studies might be
due to an inherent difference in reward function in general or due
to differences in operant learning.
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Intracranial Self-Stimulation
Among the paradigms used to study the rewarding effects of
drugs the intracranial self-stimulation (ICSS) procedure is also
one. This experimental paradigm has been used to study the
cerebral circuits mediating reward and was fundamental in
the formulation of the reward concept and its application to
the current theories of drug consumption and addiction (Olds
and Milner, 1954). In this paradigm operant responding is
maintained by pulses of electrical brain stimulation delivered
through electrodes targeting the medial forebrain bundle at the
level of the lateral hypothalamus (Negus and Miller, 2014).
Among the different variety of ICSS procedures employed, two of
them have been extensively used and validated to study the effects
of drugs of abuse: the discrete-trial current-intensity (DT-CI) and
the rate-frequency curve shift (R-FCS) (Markou and Koob, 1993).
The minimal current needed to promote the ICSS response, is
considered a measure of the subject’s “reward threshold.” It has
been demonstrated that drugs of abuse cause a reduction of the
ICSS reward threshold in some brain areas (Kornetsky and Bain,
1992; Wise, 1996) thus increasing the rewarding effect of brain
stimulation.
Only limited evidence is available on differences between F344
and LEW strains by using the ICSS paradigm to investigate
differences in reward function. While the mean rate-frequency
of brain stimulation reward function in the medial forebrain
bundle obtained in F344, LEW, and SD rats was not different,
administration of 1.0mg/kg of THC lowered the reward
threshold to a greater extent in LEW strain than SD rats, while
F344 rats did not appear to be affected by THC (Lepore et al.,
1996). This is consistent with microdialysis studies showing that
LEW and SD rats are sensitive to the DA releasing properties
of THC while F344 rats are not (Chen et al., 1991; Tanda
et al., 1997; Cadoni et al., 2008, 2015). In another study using
lateral hypothalamic brain stimulation, no difference between
strains was observed in the ability of cocaine to potentiate brain
stimulation reward (Ranaldi et al., 2001). The observed lack of
difference between strains might be due to the drug doses used,
given the different effect of low vs. high doses of cocaine on DA
transmission in the NAc shell and LEW preference for high doses
of cocaine (Cadoni and Di Chiara, 2007; Picetti et al., 2010).
Impulsivity
Impulsivity is a multifaceted concept mediated by different
neural processes, influencing individual behavior in everyday
life. It has been defined as the inability to wait, tendency to act
without forethought, insensitivity to consequences, preference
for immediate over delayed gratification, inability to inhibit
inappropriate behavior, tendency to engage in risky behavior,
and desire to seek out novel sensations (Reynolds, 2006). Thus,
impulsivity has been categorized in two dimensions: impulsive
action (motor disinhibition) as the inability to inhibit behavior,
and impulsive choice (impulsive decision making) as preference
for immediate over delayed rewards even when the immediate
reward is smaller (Jupp and Dalley, 2014). While it is a part of
healthy behavior, maladaptive expression of this trait has been
associated with a variety of neuropsychiatric disorders. Thus,
impulsivity is a core feature of addiction and decades of research
have widely demonstrated that impulsivity is antecedent to
development of drug addiction (Jupp and Dalley, 2014). The fact
that impulsivity is regarded as contributing to the development
of addiction, predicting initial drug use, risk for addiction and
rate of relapse, as well as response to treatment, together with
the fact that drug abuse might affect levels of impulsivity, has
unfortunately also been a source of confusion, making unclear
whether impulsivity was a cause or a consequence of chronic drug
use. The use of animal models has helped to clarify this issue
(Winstanley et al., 2010; Jupp et al., 2013).
Studies on impulsivity in these two strains have highlighted
how LEW rats are more impulsive than F344 in several
experimental paradigms and, as we will see further on, how
this behavioral feature can be correlated to other biochemical
characteristics of this strain.
In delay discounting tasks, measuring impulsive choice, LEW
rats appear to be more impulsive than F344 strain (Anderson and
Elcoro, 2007; Madden et al., 2008; Anderson and Diller, 2010;
García-Lecumberri et al., 2011; Huskinson and Anderson, 2012;
Stein et al., 2012) choosing smaller immediate reinforcers, rather
than delayed larger reinforcers and this was true in the case of
food reinforcer and morphine infusions.
In a study assessing response impulsivity (or impulsive
action), characterized by behavioral disinhibition and associated
risky behaviors, LEW rats show more premature responses
than F344 rats during the Five Choice Serial Reaction Time
Task (5-CSRTT) indicating higher levels of response impulsivity
(Hamilton et al., 2014). In autoshaping procedure, LEW rats
acquire the autoshaping response faster and performed the
autoshaping response at higher rates than F344 rats (Kearns
et al., 2006). Autoshaping has been considered to be a form of
impulsive behavior (Tomie et al., 1998; Monterosso and Ainslie,
1999) and in particular a form of impulsive action (Winstanley
et al., 2004) likely related to impulsive decision-making due to
the fundamental role played by CS-US associations in regulating
goal-seeking behavior (Winstanley et al., 2005).
TheNAc is a key component of the neural processes regulating
impulsivity, with afferent and efferent connections and the
complex interplay of major neurotransmitter systems within it,
making this area a crucial site of behavioral output (Basar et al.,
2010). Given the central role played by dopamine (DA) and
serotonin (5-HT) in impulsivity, as well as in drug reward, it
is conceivable that differences observed between strains might
be related to differences in DA and 5-HT transmission in these
strains.
Lower DA D2 receptor densities in the striatum and NAc core
and lower DA D3 receptor densities in the NAc shell have been
observed in LEW as compared with F344 rats (Flores et al., 1998)
and therefore would be consistent with a trait of high impulsivity
(Dalley et al., 2007; Besson et al., 2010; Moreno et al., 2013).
In addition, the lower basal 5-HT levels observed in the NAc
and prefrontal cortex (PFCx) of LEW rats (Selim and Bradberry,
1996), as well as the fewer 5-HT receptors in the hippocampus
and PFCx (Burnet et al., 1996) have been linked to high levels of
impulsivity (see Jupp and Dalley, 2014 for a review).
Although differences between strains in other
neurotransmitter systems might concur to determine a high
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impulsive phenotype (Hayes et al., 2014), as well the reported
link between impulsivity and addiction (Jupp and Dalley, 2014),
the NAc appears to be a crucial area in regulating not only
impulsivity but also drug reward. We will highlight differences
between strains not only in basal conditions but also in adaptive
changes of DA mesolimbic transmission following repeated drug
exposure.
Anxiety
Somehow contrasting results exist concerning differences in
the level of anxiety between the strains. While some studies
reported no difference in the level of anxiety between strains
(Chaouloff et al., 1995; Rex et al., 1996; Cadoni et al., 2015)
others reported an increased anxious state in LEW rats (Kulikov
et al., 1997; Ramos et al., 1997; Cohen et al., 2006) that has
been related to the hypo-responsivity of their HPA system. These
discrepancies might be due to the different anxiety models used
that have failed to produce an unique anxiety factor, which
also suggests that different experimental models may assess
different forms of anxiety (File, 1991; Belzung and Le Pape, 1994).
Moreover, previous stressful experiences, novel environment,
and handling might have affected animal behavior in anxiety
tests (Andrews and File, 1993; Rodgers and Cole, 1993). As
an example, handling has been reported to increase open arms
entries (decreased anxiety) in plus maze testing, while exposure
to a novel environment immediately prior of plus maze testing
might enhance or decrease anxiety depending on the strain of the
animal.
INDICES OF DOPAMINE SYSTEM
FUNCTIONALITY
In vitro Studies
Studies aimed at identifying differences in DA transmission
functionality between LEW and F344 rats have shown that
LEW rats, compared with F344, have higher levels of tyrosine
hydroxylase (TH, the rate-limiting enzyme for DA synthesis) in
the ventral tegmental area (VTA), although having fewer TH
positive neurons, thus suggesting higher levels of TH per VTA
neuron in this strain (Beitner-Johnson et al., 1991; Harris and
Nestler, 1996; Haile et al., 2001). In the NAc, LEW rats show
lower levels of TH than F344, while no difference in TH levels or
number of positive neurons was detected in the substantia nigra
(SN) and in the caudate-putamen (CPu) (Beitner-Johnson et al.,
1991; Harris and Nestler, 1996). It is interesting to note that this
same pattern of TH expression, i.e., increased levels in VTA and
decreased levels in the NAc observed in drug naive LEW vs. F344
rats, has been observed in outbred SD rats after chronicmorphine
and cocaine (Beitner-Johnson and Nestler, 1991).
Analysis of DA transporter (DAT) levels revealed that LEW
rats have lower levels in CPu, NAc, and olfactory tubercle than
F344 counterparts (Flores et al., 1998; Haile et al., 2001; Gulley
et al., 2007) as well as a lower DAT activity as detected by a slower
in vivo clearance of locally applied DA in CPu and NAc (Gulley
et al., 2007). Interestingly, reduced TH levels in DA terminals in
striatum have been found in heroin addicts (Kish et al., 2001),
as well reduced DAT levels in methamphetamine addicts (Chang
et al., 2007) and in tobacco and marijuana smokers (Leroy et al.,
2012).
LEW and F344 rats also differ in DA receptor densities in
basal conditions, as well as after exposure to drugs of abuse. LEW
rats have been reported to have lower levels of DA D3 receptors
in the shell of NAc and olfactory tubercle, lower levels of D2-
like receptors in CPu and NAc core compared with F344 rats,
while no difference between strains has been observed in D1-like
receptor densities in NAc and CPu (Flores et al., 1998). These
findings are consistent with lower levels of Giα1/2 and higher
levels of adenylate cyclase and cyclic AMP-dependent protein
kinase observed in LEW compared with F344 strain (Guitart
et al., 1993; Brodkin et al., 1998; Haile et al., 2001).
It is interesting to observe that lower levels of D2 and
D3 receptors in the NAc might be consistent with the higher
impulsivity of this strain compared with F344 and their
vulnerability to drug addiction (Anderson andWoolverton, 2005;
Kearns et al., 2006; Madden et al., 2008; Huskinson et al., 2012;
Hamilton et al., 2014) given the evidence that lower levels of
D2/D3 receptors have been reported to be predictive of trait
impulsivity (Dalley et al., 2007; Jupp et al., 2013). Moreover,
reduced levels of DA D2 receptors have been detected not only
in animals repeatedly exposed to drugs of abuse but also in
human addicts (Volkow et al., 1993, 1996, 2001, 2002) while high
levels of D2 receptors appear to be protective against alcohol
dependence (Thanos et al., 2001; Volkow et al., 2006). In addition
several genetic studies in humans have linked D2 receptor gene
polymorphisms with addiction to different substances of abuse
(Comings and Blum, 2000; Noble, 2000; Le Foll et al., 2009;
Agrawal et al., 2012; Gorwood et al., 2012).
In contrast with the above finding, another study showed
lower levels of D1-like receptors in the olfactory tubercle and SN
and D2-like receptors in the piriform cortex and hippocampal-
CA1 in LEW compared with F344 rats, while showing higher
D2-like binding in CPu and no difference in the NAc (Sánchez-
Cardoso et al., 2009). Lower D1 receptor levels have been also
reported in cingulate cortex and higher levels in several areas of
hippocampus, thalamus, and SN pars reticulata of LEW when
compared with F344 rats (Martín et al., 2003). The lower D1
receptor levels in SN and the higher D2 levels in the CPu have
been suggested to reflect a heightened dopaminergic tone in the
LEW strain (Sánchez-Cardoso et al., 2009).
This same study also analyzed changes in DA receptor
densities after morphine self-administration, showing that in
most brain regions analyzed LEW rats displayed a decrease
in D1-like binding after morphine self-administration while
F344 animals showed an increment, thus suggesting different
adaptive changes of DA transmission following morphine self-
administration. Additionally, D2 receptors of LEW rats were
down regulated after morphine self-administration in the CPu
and NAc shell and core while in F344 rats they appeared to be
increased in the same areas.
Other interesting differences between the two strains are
the lower levels of cholecystokinin (CCK) immunoreactivity
in the VTA and the lower extraneuronal levels of CCK8 and
CCK2 receptors detected in the NAc of LEW as compared
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with F344 strain (Harris and Nestler, 1996; Noble et al., 2012).
In fact, the neuropeptide CCK, co-localized with DA in a
subpopulation of VTA neurons, but also in SN pars compacta
(Hökfelt et al., 1980; Seroogy et al., 1989), has been hypothesized
to be involved in modulating the emotional and motivational
functions of morphine (Faris et al., 1983) through an action on
DA mesolimbic system (Wang et al., 1985; Voigt et al., 1986;
Ladurelle et al., 1993). Thus, low levels of CCK in the NAc has
been hypothesized to increase the reinforcing effects of drugs of
abuse (Rotzinger and Vaccarino, 2003; Noble et al., 2012).
In vivo Studies
Given the pivotal role of mesolimbic DA transmission in
the motivational and rewarding properties of drugs of abuse,
extensive research has been focused on investigating differences
in mesolimbic DA function and responsiveness to drugs. As
reported above, LEW and F344 rats differ in several indices of
DA transmission. Therefore, it was predictable that they would
have shown differences in DA transmission as recorded by in vivo
techniques. Electrophysiological and brain microdialysis studies
have been useful to unveil these differences.
With regards to electrophysiology of DA neurons, only two
studies have investigated differences between F344 and LEW
strains. Minabe et al. (1995), by using in vivo extracellular
recording techniques, showed that LEW rats have a significantly
lower number of spontaneously active DA neurons in the VTA
and SN pars compacta compared with F344 rats, consistent with
their lower number of TH positive neurons (Harris and Nestler,
1996). Spontaneously active DA neurons in the VTA of LEW
rats display significantly greater % events as burst and % of
cells exhibiting burst firing pattern compared with F344 strain,
although no difference was observed in the % of spikes in bursts
as well as in the variation coefficient (Minabe et al., 1995).
Early microdialysis studies have led to contrasting results,
likely due to differences between studies in targeting specific and
defined areas.
Thus, while Camp et al. (1994) reported greater increases
in extracellular DA in the ventral striatum of LEW rats after
different doses of methamphetamine and cocaine, Strecker et al.
(1995) did not find significant differences between LEW and
F344 rats in the increase of extracellular DA in the NAc
following different doses of cocaine. Fernandez et al. (2003a)
did not observe differences in DA increase after a low dose
of methylendioxymethamphetamine (MDMA), while reporting a
greater DA increase in the NAc shell of F344 strain with a high
dose. These early studies did not report any significant difference
in basal DA levels between strains, but showed markedly lower
levels of DOPAC and HVA (DA metabolites) in LEW compared
with F344 rats (Camp et al., 1994; Strecker et al., 1995), as
well as higher plasma and brain levels (two to three-fold) of
methamphetamine and cocaine in LEW strain (Camp et al., 1994
but see also Kosten et al., 1997), thus suggesting differences not
only in DA clearance but also in drug pharmacokinetics.
Another study aimed to investigate the effect of ethanol on
mesolimbic DA transmission did not show differences between
strains after 0.5 and 2.0 g/kg i.p., while administration of 1.0 g/kg
increased DA only in F344 strain (Mocsary and Bradberry, 1996).
Sziraki et al. (2001) while reporting a greater DA increase in the
NAc shell of LEW rats after nicotine and a greater increase after
amphetamine in F344 strain, also observed basal DA levels three
times higher in F344 vs. LEW rats.
Given these somewhat contrasting results we performed
a systematic study to evaluate differences between strains in
mesolimbic DA transmission responsiveness to different classes
of drugs of abuse in the NAc shell and core. In fact, it is today
well recognized that these two subdivision of theNAc are not only
anatomically and functionally distinct but also play different roles
in mediating locomotor, motivational and reinforcing properties
of drugs of abuse. DA in the NAc shell is involved in reward
encoding, incentive learning and thus mediating motivational
valence. On the other hand, DA in the NAc core appears to be
involved in conditioned responding, based on stimulus-outcome
association, and thus in Pavlovian cue encoding and in goal
directed actions, playing a role in selection between actions of
differing value (Di Chiara, 2002; Di Chiara et al., 2004; Ikemoto,
2007; Bromberg-Martin et al., 2010; Saddoris et al., 2013).
Our studies have shown that although basal DA levels in the
shell and core of NAc were not significantly different between
strains, LEW rats display in general a higher DA responsiveness
than F344 rats to morphine, cocaine, amphetamine, nicotine and
(THC), although some exceptions were observed depending on
the drug dose and the area analyzed (shell vs. core).
Following cocaine challenge, a greater response in the NAc
core at doses of 5 and 10mg/kg was observed, while a greater
response in the NAc shell was obtained at 20mg/kg in LEW
compared with F344 rats (Cadoni and Di Chiara, 2007).
Following challenge with amphetamine, an increased DA
release in the NAc core of LEW rats was observed at any drug
dose tested (0.25, 0.5, and 1.0mg/kg) while in the NAc shell DA
response was greater in LEW after the lower dose and greater in
F344 rats after the higher dose.
Morphine administration elicited a greater DA response in
the NAc shell of LEW rats except at the lowest dose (1.0mg/kg)
and in the core at the lowest and highest dose but not after the
intermediate dose (Cadoni and Di Chiara, 2007).
Nicotine administration elicited higher DA increase in theNAc
shell of LEW rats except at the highest dose tested and at all doses
in the NAc core, while an increase in this area was not observed
in F344 strain (Cadoni et al., 2009).
Moreover,THC administration elicited a selective DA increase
in the NAc shell of LEW rats while it did not affect DA
transmission in F344 rats (Cadoni et al., 2015), thus in agreement
with previous studies showing that LEW rats are the most
sensitive, among different rat strains, to the rewarding and DA
increasing properties of THC (Chen et al., 1991; Lepore et al.,
1996).
The results above reported are consistent with previous CPP
and self-administration studies showing a greater morphine,
cocaine and nicotine CPP and SA in LEW as compared with
F344 rats, with the only exception being amphetamine, which
induces a greater CPP in F344 strain (Stöhr et al., 1998). We
suggested that the reinforcing properties of the drug in CPP
paradigms might depend on the relative ratio (shell vs. core) of
DA transmission stimulation rather than on the absolute DA
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increase obtained in the shell or core of NAc (Cadoni and Di
Chiara, 2007), given the different roles played by DA in the two
subdivisions of the NAc in mediating drug reinforcing properties
and motivated behavior (Fenu et al., 2006; Spina et al., 2006).
Other factors to be considered in evaluating drug effects on
mesolimbic DA transmission are differences of these two strains
in other neurotransmitter systems (serotonin, glutamate, GABA,
endocannabinoid, opioid) as well as their different HPA activity,
which play an important role in the final effect of the drug on DA
transmission, particularly of psychostimulant drugs.
Apart from being differently sensitive to the DA releasing
effects of different drugs of abuse, LEW rats compared with
their F344 counterparts appear to develop different adaptive
changes in mesolimbic DA transmission. Thus, while adult and
adolescent SD (Cadoni and Di Chiara, 1999, 2000; Cadoni
et al., 2000, 2008) and F344 rats (Cadoni et al., 2015) show
a reduced or unchanged DA transmission responsiveness in
the NAc shell and an increase in the NAc core, after repeated
non-contingent exposure to different drugs of abuse, LEW rats
display an increased responsiveness of DA transmission in the
NAc shell after adolescent THC exposure (Cadoni et al., 2015).
Sensitization of DA transmission in the NAc core is not always
observed, but that may be due to the fact that LEW rats have
already an increased DA responsiveness in the NAc core at basal
conditions (Cadoni and Di Chiara, 2007; Cadoni et al., 2009).
These data are particularly intriguing because they suggest that
LEW rats, even after repeated exposure to the drug, maintain
an unchanged or even enhanced motivational valence, incentive
arousal or reward encoding of the drug stimuli (Di Chiara and
Bassareo, 2007; Bromberg-Martin et al., 2010; Saddoris et al.,
2013).
VULNERABILITY TO STRESS
Copying with aversive situations is the result of complex
information processing and defensive response expression.
The hypothalamic-pituitary-adrenocortical (HPA) axis, activated
by stressful events leading to the release of corticosteroids
(cortisol in humans and corticosterone in rodents), is a key
structure of the stress reaction. Activation of the HPA axis
gives rise to a cascade of events involving the release of
corticotropin releasing factor (CRF) from the paraventricular
nucleus (PVN) of the hypothalamus that leads to enhanced
secretion of adrenocorticotropic hormone (ACTH) from the
pituitary. ACTH in the general circulation stimulates the
secretion of corticosteroids in the adrenal cortex.
In the brain corticosteroids bind to two types of receptors:
mineralocorticoid receptor (MR or Type I) and glucocorticoid
receptor (GR or Type II) (Gallagher et al., 2009). GRs are
widely distributed in the brain in cortical as well in limbic areas,
while MRs have been detected in hippocampal, thalamic, and
hypothalamic areas. MRs have greater affinity for corticosterone
(CORT) thus being almost saturated at basal levels, while GR
occupancy increases during circadian peak or stressful stimuli
(Reul and de Kloet, 1985). An interesting observation for our
discussion is the localization of GRs on DA neurons of VTA
and SN (Hensleigh and Pritchard, 2013) thus being able to
directly affect DA neuron functionality (Marinelli et al., 1994,
1998; Piazza and Le Moal, 1996; Piazza et al., 1996; Graf et al.,
2013), while DA transmission exerts a negative control on
corticosteroids receptors (Casolini et al., 1993).
Extensive research has been made on differences in the HPA
responsiveness of these two strains also because they are used as
a model of different susceptibility to inflammatory diseases, given
the link between HPA responsiveness and immune function
(Elenkov et al., 2008;Macho et al., 2008; Silverman and Sternberg,
2012).
Stress and Addiction
Substantial evidence shows that HPA axis and corticosteroids
are involved in the process of addiction (Sarnyai et al., 2001;
Koob, 2009; Vinson and Brennan, 2013) and that substances
of abuse are able to activate HPA axis by themselves (Armario,
2010). Thus, the difference in HPA axis responsiveness between
these two strains (Kosten and Ambrosio, 2002) offers a unique
opportunity to further investigate the role of vulnerability to
stress in relation to addiction vulnerability.
Although it is well recognized that the HPA axis and
corticosteroids are involved in drug sensitivity and in the process
of addiction, what is less clear is whether individuals at risk of
developing addiction have a heightened or a blunted response
of HPA to stressful stimuli, thus being less or more sensitive to
relapse after stressful stimuli or being less or more successful at
quitting drug abuse (Lovallo, 2006; Schumann, 2006; Koob and
Kreek, 2007; Fox et al., 2009; Paris et al., 2010; McKee et al., 2011;
Sinha, 2011; van Leeuwen et al., 2011; Evans et al., 2012; Vinson
and Brennan, 2013; Goeders et al., 2014). On the other hand in
pre-clinical studies while it was reported that locomotor response
to stress, anxious phenotype and high corticosterone (CORT)
levels were related to heightened drug self-administration, later
studies demonstrated that these factors were not predictive of
development of addiction-like behavior (see Piazza and Deroche-
Gamonet, 2013 for a review).
HPA Axis Responsiveness in F344 and LEW
Rats
Under basal conditions no difference was observed between
strains in CRF mRNA in PVN, ACTH and CORT serum levels,
and in adrenal weight, as well as in hippocampal GR and MR
mRNA (Sternberg et al., 1992; Gómez et al., 1996; Grota et al.,
1997; Baumann et al., 2000; Ergang et al., 2014, 2015). At variance
with the above studies, other authors have found reduced CORT
serum levels, higher GR receptor levels in thymus, lower MR
levels in hippocampus and pituitary, and significantly lower levels
of corticosteroid-binding globulin (CBG) in LEW compared with
F344 and SD strain (Dhabhar et al., 1993; Smith et al., 1994;
Macho et al., 2008; Table 2).
Different pulsatile characteristics of the HPA have been
observed between strains depending on sex, with female LEW
rats showing circadian variation of CORT plasma concentrations
which was not present in female F344 rats (Griffin andWhitacre,
1991; Windle et al., 1998), thus affecting CORT response to stress
stimuli depending on the phase (rising or falling) of the basal
pulse. While male F344 rats show significantly higher diurnal, as
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well as stress induced, CORT levels compared with LEW and SD
rats, returning rapidly to basal levels after stress differently from
LEW, male LEW rats show a blunted CORT circadian variation
compared with F344 (Griffin and Whitacre, 1991; Dhabhar et al.,
1993; Gómez et al., 1996). This finding is of particular importance
in experimental protocols conducted at different time of the day.
Several studies (Table 2) have shown differences between
strains in HPA axis activation following different kinds of acute
stress. Reduced CRF mRNA expression after restrain stress in
the PVN has been reported in LEW as compared with F344
rats (Sternberg et al., 1992), or unchanged post footshock stress
(Rivest and Rivier, 1994). Plasma ACTH and CORT levels
in response to different kinds of stress are reduced in LEW
compared with F344 rats (Sternberg et al., 1992; Dhabhar et al.,
1993; Rivest and Rivier, 1994; Shurin et al., 1995; Stöhr et al.,
2000; Moncek et al., 2001; Ergang et al., 2014) but also compared
with other strains of rats (Armario et al., 1995; Gómez et al., 1998;
Deutsch-Feldman et al., 2015). In this regard, SD rats have been
reported to have intermediate responses between F344 and LEW
strains (Sternberg et al., 1992; Dhabhar et al., 1993). Another
study using acute immobilization stress while confirming the
above findings about lower ACTH and CORT levels in LEW
compared with F344 strain, reported significantly higher CORT
concentration in the adrenal cortex of LEW than F344 rats
(Moncek et al., 2001).
Interestingly, in a study aimed to evaluate the influence of
handling and injection protocols on HPA response, differences in
CORT blood concentrations have been observed between LEW
and SD strain (Deutsch-Feldman et al., 2015). While CORT
concentrations in SD rats decreased after continued handling, in
LEW rats they remained constant. The fact that this attenuation
does not extend to the ACTH response suggests an effect
at the adrenal level. This finding underscores the importance
of minimizing stress associated with experimental procedures
that might have different impacts on the rat strain used, thus
sometimes leading to inconsistent results.
Experimental manipulation of endogenous negative
glucocorticoid feedback by dexamethasone administration
showed a greater reduction of ACTH and CORT plasma levels
in response to acute stress (tail shock) in LEW as compared
with F344 rats, while pharmacological adrenalectomy causes an
increase in ACTH levels in F344 but not in LEW rats following
the same acute stress (Gómez et al., 1998).
After chronic immobilization stress a similar up-regulation of
CRF mRNA expression in the hypothalamic PVN was observed
in the two strains, while ACTH serum levels were increased in
LEW but not in F344 rats; vice versa basal CORT serum levels
were increased in F344 but not in LEW (Gómez et al., 1996).
Moreover, F344 rats did not show habituation to prolonged stress
exposure of the ACTH and CORT response compared with LEW
as well as SD rats (Dhabhar et al., 1997).
A short-term variable stress protocol also stimulates the
expression of amygdalar CRF only in LEW and UNC2/UCN3
(urocortins 2/3) only in F344 rats (Ergang et al., 2015). The
observed CRF increase in amygdala following stress in LEW, but
not in F344 rats, is of particular interest since it has been involved
in addiction development as well in relapse mechanisms (Koob,
2015; Zorrilla et al., 2014).
It is also worth noting the finding that prenatal stress
differentially affects expression and processing of hippocampal
brain-derived neurotrophic factor (BDNF) in the offsprings
of the two strains. Thus, LEW (but also SD) rats show a
decreased BDNF mRNA expression immediately after stress
instead of showing increased levels, and also a decreased amount
of available proBDNF and mature BDNF protein suggesting a
higher vulnerability to prenatal stress compared with F344 strain
(Neeley et al., 2011).
Differences between strains are not limited to the main players
of HPA activity, but extend to other peptides playing key roles
in the regulation of HPA activity, in basal conditions as well
as following stress. Thus, LEW rats constitutively have higher
levels of 11β-hydroxysteroid dehydrogenase type 1 (11HSD1),
an enzyme that regulates the conversion of glucorticoids from
inactive to active form, in the PVN and pituitary, while having
lower levels in PfCx, ventral CA1, CA3 areas of hippocampus,
and adrenal cortex (Ergang et al., 2015). Stress up-regulates
11HSD1 in the prefrontal cortex and lateral amygdala in
LEW rats, whereas in F344 11HSD1 is up-regulated in central
amygdala, hippocampal CA2, and ventral CA1, while no effect
was detected in the PVN, pituitary gland and adrenal cortex of
both strains (Ergang et al., 2015).
Differential activation of GRs in neural and immune tissue
during stress was observed, with F344 strain exhibiting the
highest receptor activation in brain tissue (hippocampus,
hypothalamus, cortex, and pituitary) while LEW rats exhibiting
the lowest magnitude of GR activation in immune tissues
(Dhabhar et al., 1995). A similar down-regulation of GR
mRNA following chronic stress or variable stress protocol in
the dorsal but not ventral CA1 area of hippocampus was
observed in the two strains (Gómez et al., 1996; Ergang et al.,
2014).
Differential reactivity of HPA in the two strains is not limited
to stress exposure but also extends to exposure to drugs of
abuse. Thus, LEW compared with F344 rats show a reduced
CORT response to nicotine (Grota et al., 1997) and morphine
challenge (Baumann et al., 2000). Following administration of
different doses of cocaine, LEW rats display reduced CORT
response compared with F344 strain, but show higher response
when expressed as percent of change, while plasma ACTH
concentrations, as well as percentage of control response, were
dramatically increased in LEW rats after 40mg/kg of cocaine
(Simar et al., 1996). Interestingly increased levels of CORT and
ACTH were observed in F344 rats during the first 24 h of
withdrawal after an extended access paradigm of cocaine SA,
while LEW rats did not show any change although they escalated
their cocaine intake during this experimental procedure (Picetti
et al., 2010).
As mentioned at the beginning of this section, HPA activity
and immune function are strictly linked (Silverman and
Sternberg, 2012). Given that the neuroimmune system appears
to be involved not only in aversive and stress response but also
in affective disorders and drug addiction (Crews et al., 2011;
Cui et al., 2014) the above reported vulnerability of LEW rats
to develop not only drug addiction but also neuroinflammatory
diseases (Elenkov et al., 2008) offers a unique opportunity
to further investigate the role of neuroinflammation in the
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pathophysiology of addiction (Cui et al., 2014; Ray et al., 2014;
Rodrigues et al., 2014).
In conclusion, although LEW rats appear to have a hypo-
responsive HPA axis in certain conditions it is not clear from the
literature (Armario et al., 1995; Stöhr et al., 2000; Grakalic et al.,
2006; Kosten and Miserendino, 2012) if this phenotype might
be associated with a lower or higher vulnerability to stress and
therefore being a factor of vulnerability to addiction. The fact
that, in experimental models of post-traumatic stress disorders
(PTSD), LEW rats appear to bemore susceptible than F344 rats to
PTSD-like responses, suggests that blunted HPA response might
be a factor of vulnerability to stressful events and recovery from
them (Cohen et al., 2006). Thus, it might be hypothesized, on
the basis of previous considerations, that a reduced HPA activity
might be a vulnerability factor given the reduced ability of the
LEW strain to cope with adverse or stressful events. Further
studies are clearly needed to clarify this issue.
DIFFERENCES IN OTHER
NEUROTRANSMITTER SYSTEMS
Although DA system is a key player in the processing of reward
and motivation and thus in drug addiction, differences in other
neurotransmitter systems may concur to shape an addiction
prone phenotype.
One of these systems playing a critical role is the
endocannabinoid system (Solinas et al., 2008; Melis and
Pistis, 2012; Panagis et al., 2014; Wenzel and Cheer, 2014).
Early studies suggested that LEW rats are more sensitive to
the rewarding effect of THC thus leading us to hypothesize the
existence of differences between strains in the endocannabinoid
system (Chen et al., 1991; Lepore et al., 1996; Cadoni et al.,
2015). However, only few studies have investigated differences
between the two strains in indices of endocannabinoid system
functionality. An analysis of several brain areas showed lower
cannabinoid (CB) receptor binding in the globus pallidus (GP)
and a higher cannabinoid receptor 1 (CNR1) gene expression in
the PfCx of LEW compared with F344 rats (Coria et al., 2014).
In the hippocampus, LEW rats show lower expression of CB1
receptors and higher CB2 receptors than F344 rats (Rivera et al.,
2013). Moreover, F344 rats have been reported having reduced
levels of CB1 receptors and FAAH in the hippocampus compared
with Wistar rats (Brand et al., 2012).
As regards levels of enzymes mediating synthesis and
degradation of endocannabinoids, LEW strain displays increased
expression of the genes encoding fatty acid amide hydrolase
(FAAH), monoacylglicerol lipase (MAGL) in the PfCx and
in the case of FAAH also in the NAc (Coria et al., 2014).
Moreover, the N-acyl phosphatidylethanolamine phospholipase
D (NAPE-PLD)/FAAH ratio is lower in the PfCx, NAc, and
CA3 hippocampal field of LEW as compared with F344 rats,
suggesting higher anandamide levels in F344 strain (Rivera et al.,
2013; Coria et al., 2014).
Given the pivotal role of the endocannabinoid system in
brain development (Harkany et al., 2008), differences in levels
of synthesis and degrading enzymes, and in receptor density
and distribution, might affect adolescence vulnerability of these
strains to various drugs of abuse. Indeed, we have reported
that adolescent exposure to THC induces markedly different
effects on reward function in the two strains (Di Chiara et al.,
2013; Cadoni et al., 2015). Differences in the endocannabinoid
system acquire a particular relevance in the light of recent
evidence on the control of midbrain DA neurons activity by
endocannabinoids in the VTA (Barrot et al., 2012; Melis and
Pistis, 2012; Wang and Lupica, 2014). It is worth noting that in
human genetic studies genetic variation in the gene coding for the
CB1 receptor (CNR1), as well as for FAAH and MAGL (MGLL)
has been reported to be associated not only with cannabis
dependence, but also with substance use disorder in general
and impulsive personality traits (Agrawal and Lynskey, 2009;
Proudnikov et al., 2010; Wang et al., 2011; Bidwell et al., 2013;
Clarke et al., 2013; Demers et al., 2014).
With regard to differences between strains in glutamate (GLU)
and GABA transmission it has been reported that LEW rats have
lower basal levels of Glu in the PfCx and NAc shell and core and
lower GABA levels in the NAc core (Selim and Bradberry, 1996;
Miguéns et al., 2013).
Cocaine SA has been reported to alter long term potentiation
(LTP) depotentiation in the hippocampus of LEW, but not F344
rats (Miguéns et al., 2011) suggesting that long-term exposure
to cocaine impairs the synaptic plasticity that supports learning.
Moreover, these neurotransmitter systems appear to respond
differently after cocaine priming reinstatement in a SA paradigm
with LEW rats showing sharp increase in GLU levels and F344
rats showing an increase in GABA levels (Miguéns et al., 2013).
This result has been hypothesized to be at the basis of the greater
vulnerability of LEW rats to cocaine reinstatement.
Another study showed that long term depression (LTD)
induced by GLU agonist NMDA is partially abolished in
hippocampal slices of LEW rats exposed during adolescence to
cocaine, while in F344 rats hippocampal NMDA-LTD is partially
inhibited independently of cocaine treatment, suggesting lack
of plasticity of this strain which could be related to its poor
performance in spatial memory tasks (Fole et al., 2015). It would
be interesting to investigate differences between strains in LTD in
the NAc given that impaired LTD has been suggested to be related
to transition to cocaine addiction in an animal model (Kasanetz
et al., 2010).
Moreover, LEW rats have been reported to have significantly
higher benzodiazepine binding sites (Bmax) in hypothalamic
preparations compared with F344 rats but show no difference
in binding affinities (Kd). These differences appear only partially
related to strain differences in CORT levels (Smith et al., 1992),
and suggest a different GABA functionality in this area.
Several lines of evidence indicate that LEW strain has a
reduced serotonin (5-HT) neurotransmission function. Thus, a
reduced activity of tryptophan hydroxylase (the rate-limiting
enzyme in 5-HT biosynthesis) in hippocampus (Chaouloff et al.,
1995) and higher hippocampal extracellular 5-HT basal levels
has been observed in LEW vs. F344 rats (Fernandez et al.,
2003b). In the NAc LEW rats display lower basal 5-HT levels
compared with F344 counterparts but increased 5-HT levels
(but also GLU levels) following ethanol challenge, responses that
were absent in the F344 strain (Selim and Bradberry, 1996).
Female and male LEW rats have been shown to have lower levels
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of serotonin transporter (5-HTT) gene expression in midbrain
and hippocampal preparations and lower hippocampal 5-HT
reuptake sites compared with F344 counterparts, consistent with
the higher 5-HT levels in this area (Fernandez et al., 2003b). LEW
have significantly fewer 5-HTR binding sites in hippocampal
and frontal cortical regions and less 5-HT1A receptor mRNA
compared with SD and F344 rats (Burnet et al., 1992; Chaouloff
et al., 1995).
While a reduced 5-HT tone might be the basis of the greater
impulsivity of LEW rats, nonetheless differences in 5-HT system
function might affect reward processing given the role of this
system in reward function in general and in modulating DA
transmission in particular (Alex and Pehek, 2007; Kranz et al.,
2010).
LEW rats also appear to have a reduced opioid function. Thus,
LEW rats display lower basal dynorphin peptide levels in SN,
CPu, and VTA (but not dynorphin B) and in the pituitary gland.
Leu-enkephalinArg6 levels were also lower in these structures
and in the NAc, with the only exception of the CPu where levels
were higher in LEW compared with F344 rats (Nylander et al.,
1995).
Basal proenkephalin (PENK) mRNA expression was also
found to be reduced in CPu and NAc shell of LEW rats (Martín
et al., 1999; Sánchez-Cardoso et al., 2007).
Adaptive changes following chronic morphine were different
in the two strains with only F344 rats showing increased
dynorphin A levels in NAc and VTA and LEW showing a
decrease in VTA and hippocampus (Nylander et al., 1995).
Additionally, only LEW rats showed an increase of dynorphin
peptide levels during withdrawal. Leu- and Met-Enkephalin
peptide levels were increased in F344 rats after chronic morphine
while not affected in LEW rats. These differences acquire a
particular significance in the light of the different actions of
these peptides (dynorphin A and B act on κ opioid receptors
while enkephalin peptides act on δ and µ receptors) and
considering the known effect of these receptor activations on
DA transmission (Di Chiara and Imperato, 1988; Spanagel et al.,
1990; Devine et al., 1993).
LEW rats self-administering morphine showed a decrease of
PENK mRNA content in every area, which recovered to normal
levels during extinction, except for theNAc shell where no change
was apparent (Sánchez-Cardoso et al., 2007).
LEW rats in basal conditions display lower µ opioid receptor
(MOR) levels not only in cerebral cortex and spinal cord
(Herradón et al., 2003) but also in several other brain areas
(Sánchez-Cardoso et al., 2007) which persisted after morphine
self-administration in some of them (including CPu, NAc,
amygdala, SN pars reticulata) but not in others (Sánchez-Cardoso
et al., 2007).
In morphine self-administering rats opposite effects were
observed in the two strains with LEW rats showing increased
binding levels to MORs in CA1 and CA2 fields of the
hippocampus while F344 rats showed a decrease. An increased
binding to MORs was also observed in primary and secondary
motor cortex, M1 and M2, NAc shell and core, VTA and other
nuclei (Sánchez-Cardoso et al., 2007). The most common pattern
of changes in MORs during extinction training was a decrease
until day 7 followed by recovery until day 15, which was more
prominent in F344 rats. This increased MOR binding observed
in LEW strain might be consistent with higher scores of craving-
like reactions observed in LEW rats after repeated exposure to
heroin (Cadoni et al., 2015). It is interesting to note in this regard
that in the brains of heroin users, deceased because of overdose,
upregulation of MOR G-protein coupling has been observed in
the paranigral nucleus of VTA (Horvath et al., 2007). Increased
MOR binding was also observed in cortical areas of cocaine users,
which correlated with cocaine craving and predicted treatment
outcome (Zubieta et al., 1996; Gorelick et al., 2008; Ghitza et al.,
2010).
Moreover, functionality of MORs appears to be different
between strains and in basal conditions LEW rats show higher
functionality of these receptors than F344 rats in NAc core and
cingulate cortex, area 1 (Cg1), (Sánchez-Cardoso et al., 2007),
which is reversed after morphine SA in the lateral amygdala (La).
At the end of extinction period strain differences were preserved
only in the NAc shell, La and paraventricular thalamic nucleus
suggesting that LEW strain has a lower functional activation of µ
opioid receptors.
In summary, the endogenous opioid system seems to be
down-regulated in the LEW strain both from a structural point
of view (number of receptor binding sites and PENK gene
expression) but also from a functional one, showing different
adaptive changes in opioid receptors and PENK gene expression.
Only limited evidence exists on the noradrenergic system
function in these two strains. Herradón et al. (2006) did not
find differences in mRNA levels for α2A and a2C adrenoreceptors
in any of the areas analyzed (hypothalamus, hippocampus,
striatum and cortex) but they found lower levels of α2B
adrenoreceptors transcripts in the hippocampus and higher levels
in hypothalamus of F344 rats. TH gene expression was found to
be higher in the hippocampus and CPu of F344 as compared
with LEW rats, but a significant increase of the protein levels
was detected only in the case of hippocampus. Given the crucial
role of the hippocampus in learning and memory and thus in
drug addiction, the reported differences between strains in this
area involving not only noradrenergic transmission but other
systems (see above) as well, might play a role in the observed
strain differences in drug seeking and taking behavior.
STRUCTURAL PLASTICITY AND
DIFFERENCES IN GENES EXPRESSION
Experience dependent changes in behavior and psychological
functions such as those related to learning andmemory processes
and thus, also those occurring during development of addiction,
are the result of changes in neuronal plasticity associated with
reorganization of synaptic connections (structural plasticity) in
relevant brain circuits (Nestler, 2001; Lamprecht and LeDoux,
2004; Robinson and Kolb, 2004; Spiga et al., 2014). Several
studies have investigated the effects of contingent and non-
contingent exposure to drugs of abuse on neuron morphology
such as spine density and dendritic branching of pyramidal
cortical neurons and NAc medium spiny neurons. Indeed,
exposure to amphetamine, cocaine, nicotine, and morphine
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induces persistent changes in dendrites and dendritic spines of
neurons not only in brain regions involved in reward processing
but also in decision making and inhibitory control of behavior
(Robinson and Kolb, 2004; Spiga et al., 2014). This synaptic
reorganization, which alters the functioning of these circuits,
might explain the persistence of some behavioral aspects of
addiction such as craving.
Few studies have been performed investigating different
structural plasticity in F344 and LEW strains.
Two studies comparing the effects of morphine SA on basal
dendritic arbors of layer III pyramidal neurons in both prelimbic
(Plc) and motor cortex (Mc) found differences between LEW and
F344 strains not only after morphine SA but also in saline control
animals. In basal conditions (animals self-administering saline),
while no significant differences in pyramidal neuron morphology
were observed between Mc and Plc of F344 rats (Ballesteros-
Yáñez et al., 2007), LEW rats showed differences between areas,
having neurons with a smaller and less branched dendritic arbor,
and a higher density of spines in the Plc compared to those in
the Mc. Strain comparison in each area showed that in the Plc
LEW rats have a higher number and density of spines, and in
the Mc have higher values in several morphological parameters
(branching pattern, dendritic length, length per distance, length
per order, and number of spine) compared to F344 (Ballesteros-
Yanez et al., 2008).
Following morphine self-administration, Plc pyramidal
neurons of LEW rats had larger and longer dendritic arbors
while in the Mc there was a reduction in the size and branching
complexity of the dendritic arbors of pyramidal neurons.
Spine density was increased in both cortical regions following
morphine exposure (Ballesteros-Yáñez et al., 2007). The same
morphine exposure in F344 rats did not induce any change in
the structure of the dendritic arbors or in the spine density of
pyramidal neurons in either cortical area (Ballesteros-Yanez
et al., 2008). The above results following morphine SA would
suggest that F344 rats receive fewer excitatory inputs since the
majority of spines establish at least one excitatory GLU synapse
(Arellano et al., 2007).
Moreover, significant strain differences in the structure of
apical dendrites of hippocampal CA1 pyramidal neurons were
observed in saline and cocaine exposed animals, with LEW
strain showingmore branched and complex CA1 apical dendrites
than F344, although spine density in saline-LEW rats was lower
than that of F344 rats. As previously reported in morphine SA
studies, cocaine SA also produces different structural changes in
hippocampal CA1 pyramidal neurons in the two strains. While
cocaine SA increases spine density in apical dendrites of CA1
pyramidal cells of LEW rats, no such change was observed in
F344 rats (Miguéns et al., 2013). Cocaine SA had no effect on any
of the branch complexity parameters analyzed (Miguéns et al.,
2013). The reduced dendritic arborization observed in F344 rats
could be related to the different ability of this strain, compared
with LEW, in acquiring cocaine SA (Kosten et al., 1997; Freeman
et al., 2009). On the other hand, the effect of cocaine in increasing
spine density in LEW, but not in F344 rats, might contribute
to increased drug intake observed in this strain in extended
access paradigms (Picetti et al., 2010). An in-depth 3D analysis of
CA1 dendrites and dendritic spines in these two strains prior to
cocaine SA show that LEW rats have significantly larger dendritic
diameters but lower spine density compared with F344 strain.
After cocaine SA, proximal dendritic volume, dendritic surface
area, and spine density were increased in LEW strain, where
also an increased percentage of larger spines was observed. In
contrast, F344 rats showed decreased spine head volume after
cocaine SA (Selvas et al., 2015).
In studies on hippocampal CA1 neuronalmorphology chronic
cocaine administration during a spatial learning task increased
spine density in both strains, but to a greater extent in F344 rats,
while in saline treated animals F344 rats showed an increased
spine density following the same task (Fole et al., 2011). It
has been suggested that the increase in spine number could be
related with learning deficits and this might account for the lower
capacity of F344 rats in learning the task (Fole et al., 2011).
Thus, strain differences in hippocampal neuron morphology
might represent the anatomical substrate for differential ability
in performing spatial learning tasks.
All these observations might account for differences in
memory processing of drug reward cues thus contributing to the
different vulnerability to addiction of these two strains.
Few studies have investigated differences in gene expression
between these two strains. One, investigating genes induced and
repressed in frontal cortex andNAc, found only a limited number
of genes that were differentially expressed in the two strains
(Higuera-Matas et al., 2011). The genes that were induced in the
LEW strain were related to oxygen transport, neurotransmitter
processing, and fatty acid metabolism while genes that were
repressed in LEW rats were involved in physiological functions
such as drug and proton transport, oligodendrocyte survival and
lipid catabolism. Another study aimed at evaluating differences
in basal gene expression in NAc GABA neurons projecting
to ventral pallidum and found 322 transcripts that differed
between these two strains (Sharp et al., 2011). The observation
of a significant up-regulation in LEW rats of some genes
(Mint-1, Cask, CamkIIδ, Ncam1, Vsnl1, Hpcal1, and Car8)
involved in cellular signaling and synaptic plasticity, suggests
that these gene transcripts may contribute to altered function
of NAc GABA neurons that might predispose LEW rats to self-
administer nicotine (Sharp et al., 2011), but also other drugs.
It is noteworthy that increased Ncam1 (neural cell adhesion
molecule 1) expression appears to reduce D2 receptor levels
(Xiao et al., 2009), which inhibit NAc GABA neuron activity.
Moreover, Vsnl1 (Visinin-like 1) interacts directly with the
alpha4 subunit of the most abundant nicotinic cholinergic
receptor alpha4beta2, increasing the surface expression of
functional receptors, depending on Ca2+ concentration (Zhao
et al., 2009). This might contribute to the differential sensitivity
of these two strains to nicotine. It is interesting to note that one
of the above induced genes in LEW strain (Slc17a6 gene, coding
a vesicular glutamate transporter protein) was found to be up-
regulated in the VTA by extended alcohol and tobacco abuse
in humans (Flatscher-Bader et al., 2008), while others (Ncam1
and Vsnl1) are among genes found to be associated with drug
addiction in genome wide association studies (Li et al., 2008;
Wain et al., 2015; Zhong et al., 2015).
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CONCLUSION
Today it is well clear that the initial goal of genetic studies
to find genes with a definite contribution to substance use
disorders has been elusive (Kendler et al., 2012). It is now well
recognized that addiction, like other behavioral disorders, are
polygenic diseases influenced by several genes affecting different
neurobiological systems (Hall et al., 2013). Genes exert their
influence through their action on neurotransmitter systems, drug
metabolic pathways, transduction mechanisms and responses to
environmental stimuli, such as stressful events, and determine
individual traits, such as impulsivity, novelty/sensation seeking
or stress reactivity.
From the above reviewed studies it appears that the LEW
strain differs from F344 in several neurotransmitter systems
either in basal conditions or following exposure to drugs of
abuse. Such differences are likely at the basis of the greater
sensitivity of the LEW strain to the rewarding/reinforcing
properties of drugs of abuse. Moreover, LEW strain shows
impulsive traits that are known to predispose to substance use
disorders, but also to be a consequence of chronic drug use.
Several proteins (DA receptors and transporter; endogenous
opioid receptors and precursors; endocannabinoid receptors and
degrading enzymes; 5-HT receptors and 5-HT transporter) found
to be differentially expressed in the two strains are coded by genes
whose polymorphisms have been associated with addiction to
different substances in human genetic studies.
As highlighted in the introduction, gene-environment
interactions are also of critical importance, contributing to the
final outcome of developing a given behavioral disorder. In this
regard the striking difference between LEW and F344 strains in
their HPA axis activity might play an important role in coping
with adverse stimuli and adapting behavior. Their different HPA
axis activity might also play a significant role in response to
psychostimulants, as well the greater vulnerability of LEW strain
to neuroinflammatory disease might have a role in vulnerability
to addiction as posited by some authors.
Thus, it would be tempting to speculate that this model
might mimic several traits of a genetically vulnerable human
phenotype, although keeping in mind the complexity of the
human condition that could only be roughly reproduced in an
animal model. Nonetheless, integration of human genetic studies
by using animalmodels might increase our knowledge on the role
of genetic contribution in substance use disorders and provide
new target genes to be studied in humans helping us to find new
therapeutic approaches.
AUTHOR CONTRIBUTIONS
The author confirms being the sole contributor of this work and
approved it for publication.
ACKNOWLEDGMENTS
The author wishes to thank all the colleagues who collaborate
to the author’s reported studies. Funding by Regione Autonoma
della Sardegna (CRP-24687, LR 7/2007, bando 2010, Det.
n. 11200/1602) and Fondazione Banco di Sardegna (Prot.
n. 838/2011.218 and Prot. U956.2014/AI.838.MGB) is greatly
acknowledged.
REFERENCES
Agrawal, A., and Lynskey, M. T. (2009). Candidate genes for cannabis use
disorders: findings, challenges and directions. Addiction 104, 518–532. doi:
10.1111/j.1360-0443.2009.02504.x
Agrawal, A., Verweij, K. J., Gillespie, N. A., Heath, A. C., Lessov-Schlaggar, C.
N., Martin, N. G., et al. (2012). The genetics of addiction- a translational
perspective. Transl. Psychiatry 2, e140. doi: 10.1038/tp.2012.54
Alex, K. D., and Pehek, E. A. (2007). Pharmacologic mechanisms of serotonergic
regulation of dopamine neurotransmission. Pharmacol. Ther. 113, 296–320.
doi: 10.1016/j.pharmthera.2006.08.004
Ambrosio, E., Goldberg, S. R., and Elmer, G. I. (1995). Behavior genetic
investigation of the relationship between spontaneous locomotor activity and
the acquisition of morphine self-administration behavior. Behav. Pharmacol. 6,
229–237. doi: 10.1097/00008877-199504000-00003
Anderson, K. G., and Diller, J. W. (2010). Effects of acute and repeated nicotine
administration on delay discounting in Lewis and Fischer 344 rats. Behav.
Pharmacol. 21, 754–764. doi: 10.1097/FBP.0b013e328340a050
Anderson, K. G., and Elcoro, M. (2007). Response acquisition with delayed
reinforcement in Lewis and Fischer 344 rats. Behav. Processes 74, 311–318. doi:
10.1016/j.beproc.2006.11.006
Anderson, K. G., and Woolverton, W. L. (2005). Effects of clomipramine on self-
control choice in Lewis and Fischer 344 rats. Pharmacol. Biochem. Behav. 80,
387–393. doi: 10.1016/j.pbb.2004.11.015
Andrews, N., and File, S. E. (1993). Handling history of rats modifies behavioural
effects of drugs in the elevated plus-maze test of anxiety. Eur. J. Pharmacol. 235,
109–112. doi: 10.1016/0014-2999(93)90827-5
Arellano, J. I., Espinosa, A., Fairén, A., Yuste, R., and De Felipe, J. (2007).
Non-synaptic dendritic spines in neocortex. Neuroscience 145, 464–469. doi:
10.1016/j.neuroscience.2006.12.015
Armario, A. (2010). Activation of the hypothalamic-pituitary-adrenal axis by
addictive drugs: different pathways, common outcome. Trends Pharmacol. Sci.
31, 318–325. doi: 10.1016/j.tips.2010.04.005
Armario, A., Gavaldà, A., and Martí, J. (1995). Comparison of the behavioural and
endocrine response to forced swimming stress in five inbred strains of rats.
Psychoneuroendocrinology 20, 879–890. doi: 10.1016/0306-4530(95)00018-6
Ballesteros-Yanez, I., Ambrosio, E., Pérez, J., Torres, I., Miguéns, M., García-
Lecumberri, C., et al. (2008). Morphine self-administration effects on the
structure of cortical pyramidal cells in addiction-resistant rats. Brain Res. 1230,
61–72. doi: 10.1016/j.brainres.2008.06.128
Ballesteros-Yáñez, I., Ambrosio, E., Benavides-Piccione, R., Pérez, J., Torres, I.,
Miguéns, M., et al. (2007). The effects of morphine self-administration on
cortical pyramidal cell structure in addiction-prone lewis rats. Cereb. Cortex
17, 238–249. doi: 10.1093/cercor/bhj142
Bardo, M. T., and Bevins, R. A. (2000). Conditioned place preference: what does it
add to our preclinical understanding of drug reward? Psychopharmacology 153,
31–43. doi: 10.1007/s002130000569
Barrot, M., Sesack, S. R., Georges, F., Pistis, M., Hong, S., and Jhou, T.
C. (2012). Braking dopamine systems: a new GABA master structure for
mesolimbic and nigrostriatal functions. J. Neurosci. 32, 14094–14101. doi:
10.1523/JNEUROSCI.3370-12.2012
Basar, K., Sesia, T., Groenewegen, H., Steinbusch, H. W., Visser-Vandewalle, V.,
and Temel, Y. (2010). Nucleus accumbens and impulsivity. Prog. Neurobiol. 92,
533–557. doi: 10.1016/j.pneurobio.2010.08.007
Baumann, M. H., Elmer, G. I., Goldberg, S. R., and Ambrosio, E. (2000).
Differential neuroendocrine responsiveness to morphine in Lewis, Fischer
344, and ACI inbred rats. Brain Res. 858, 320–326. doi: 10.1016/S0006-
8993(99)02479-8
Beitner-Johnson, D., Guitart, X., and Nestler, E. J. (1991). Dopaminergic brain
reward regions of Lewis and Fischer rats display different levels of tyrosine
Frontiers in Neuroscience | www.frontiersin.org 15 February 2016 | Volume 10 | Article 13
Cadoni Modeling Genetic Vulnerability to Addiction
hydroxylase and other morphine- and cocaine-regulated phosphoproteins.
Brain Res. 561, 147–150. doi: 10.1016/0006-8993(91)90759-O
Beitner-Johnson, D., and Nestler, E. J. (1991). Morphine and
cocaine exert common chronic actions on tyrosine hydroxylase in
dopaminergic brain reward regions. J. Neurochem. 57, 344–347. doi:
10.1111/j.1471-4159.1991.tb02133.x
Belzung, C., and Le Pape, G. (1994). Comparison of different behavioral test
situations used in psychopharmacology for measurement of anxiety. Physiol.
Behav. 56, 623–628. doi: 10.1016/0031-9384(94)90311-5
Besson, M., Belin, D., McNamara, R., Theobald, D. E., Castel, A., Beckett, V.
L., et al. (2010). Dissociable control of impulsivity in rats by dopamine
d2/3 receptors in the core and shell subregions of the nucleus accumbens.
Neuropsychopharmacology 35, 560–569. doi: 10.1038/npp.2009.162
Bidwell, L. C., Metrik, J., McGeary, J., Palmer, R. H., Francazio, S., and Knopik, V.
S. (2013). Impulsivity, variation in the cannabinoid receptor (CNR1) and fatty
acid amide hydrolase (FAAH) genes, and marijuana-related problems. J. Stud.
Alcohol Drugs 74, 867–878. doi: 10.15288/jsad.2013.74.867
Blum, K., Chen, A. L., Giordano, J., Borsten, J., Chen, T. J., Hauser, M., et al.
(2012). The addictive brain: all roads lead to dopamine. J. Psychoactive Drugs
44, 134–143. doi: 10.1080/02791072.2012.685407
Bossert, J. M., Poles, G. C., Wihbey, K. A., Koya, E., and Shaham, Y.
(2007). Differential effects of blockade of dopamine D1-family receptors
in nucleus accumbens core or shell on reinstatement of heroin seeking
induced by contextual and discrete cues. J. Neurosci. 27, 12655–12663. doi:
10.1523/JNEUROSCI.3926-07.2007
Bossert, J. M., Stern, A. L., Theberge, F. R., Marchant, N. J., Wang, H. L., Morales,
M., et al. (2012). Role of projections from ventral medial prefrontal cortex to
nucleus accumbens shell in context-induced reinstatement of heroin seeking.
J. Neurosci. 32, 4982–4991. doi: 10.1523/JNEUROSCI.0005-12.2012
Brand, T., Spanagel, R., and Schneider, M. (2012). Decreased reward sensitivity
in rats from the Fischer344 strain compared to Wistar rats is paralleled
by differences in endocannabinoid signaling. PLoS ONE 7:e31169. doi:
10.1371/journal.pone.0031169
Brodkin, E. S., Carlezon, W. A. Jr., Haile, C. N., Kosten, T. A., Heninger, G.
R., and Nestler, E. J. (1998). Genetic analysis of behavioral, neuroendocrine,
and biochemical parameters in inbred rodents: initial studies in Lewis and
Fischer 344 rats and in A/J and C57BL/6J mice. Brain Res. 805, 55–68. doi:
10.1016/S0006-8993(98)00663-5
Bromberg-Martin, E. S., Matsumoto, M., and Hikosaka, O. (2010). Dopamine in
motivational control: rewarding, aversive, and alerting. Neuron 68, 815–834.
doi: 10.1016/j.neuron.2010.11.022
Brower, V. G., Fu, Y., Matta, S. G., and Sharp, B. M. (2002). Rat strain differences
in nicotine self-administration using an unlimited access paradigm. Brain Res.
930, 12–20. doi: 10.1016/S0006-8993(01)03375-3
Burnet, P. W., Mefford, I. N., Smith, C. C., Gold, P. W., and Sternberg,
E. M. (1992). Hippocampal 8-[3H]hydroxy-2-(di-n-propylamino)
tetralin binding site densities, serotonin receptor (5-HT1A) messenger
ribonucleic acid abundance, and serotonin levels parallel the activity of the
hypothalamopituitary-adrenal axis in rat. J. Neurochem. 59, 1062–1070. doi:
10.1111/j.1471-4159.1992.tb08348.x
Burnet, P. W., Mefford, I. N., Smith, C. C., Gold, P. W., and Sternberg, E.
M. (1996). Hippocampal 5-HT1A receptor binding site densities, 5-HT1A
receptor messenger ribonucleic acid abundance and serotonin levels parallel
the activity of the hypothalamo-pituitary-adrenal axis in rats. Behav. Brain Res.
73, 365–368. doi: 10.1016/0166-4328(96)00116-7
Cadoni, C., and Di Chiara, G. (1999). Reciprocal changes in dopamine
responsiveness in the nucleus accumbens shell and core and in the dorsal
caudate-putamen in rats sensitized tomorphine.Neuroscience 90, 447–455. doi:
10.1016/S0306-4522(98)00466-7
Cadoni, C., and Di Chiara, G. (2000). Differential changes in accumbens shell and
core dopamine in behavioral sensitization to nicotine. Eur. J. Pharmacol. 387,
R23–R25. doi: 10.1016/s0014-2999(99)00843-2
Cadoni, C., and Di Chiara, G. (2007). Differences in dopamine responsiveness to
drugs of abuse in the nucleus accumbens shell and core of Lewis and Fischer
344 rats. J. Neurochem. 103, 487–499. doi: 10.1111/j.1471-4159.2007.04795.x
Cadoni, C., Solinas, M., and Di Chiara, G. (2000). Psychostimulant sensitization:
differential changes in accumbal shell and core dopamine. Eur. J. Pharmacol.
388, 69–76. doi: 10.1016/S0014-2999(99)00824-9
Cadoni, C., Muto, T., and Di Chiara, G. (2009). Nicotine differentially
affects dopamine transmission in the nucleus accumbens shell and core
of Lewis and Fischer 344 rats. Neuropharmacology 57, 496–501. doi:
10.1016/j.neuropharm.2009.07.033
Cadoni, C., Simola, N., Espa, E., Fenu, S., and Di Chiara, G. (2015).
Strain dependence of adolescent Cannabis influence on heroin reward and
mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats. Addict.
Biol. 20, 132–142. doi: 10.1111/adb.12085
Cadoni, C., Solinas, M., Valentini, V., and Di Chiara, G. (2003). Selective
psychostimulant sensitization by food restriction: differential changes in
accumbens shell and core dopamine. Eur. J. Neurosci. 18, 2326–2334. doi:
10.1046/j.1460-9568.2003.02941.x
Cadoni, C., Valentini, V., andDi Chiara, G. (2008). Behavioral sensitization to delta
9-tetrahydrocannabinol and cross-sensitization with morphine: differential
changes in accumbal shell and core dopamine transmission. J. Neurochem. 106,
1586–1593. doi: 10.1111/j.1471-4159.2008.05503.x
Camp, D. M., Browman, K. E., and Robinson, T. E. (1994). The effects of
methamphetamine and cocaine on motor behavior and extracellular dopamine
in the ventral striatum of Lewis versus Fischer 344 rats. Brain Res. 668, 180–193.
doi: 10.1016/0006-8993(94)90523-1
Casolini, P., Piazza, P. V., Kabbaj, M., Leprat, F., Angelucci, L., Simon, H., et al.
(1993). The mesolimbic dopaminergic system exerts an inhibitory influence
on brain corticosteroid receptor affinities. Neuroscience 55, 429–434. doi:
10.1016/0306-4522(93)90511-D
Chang, L., Alicata, D., Ernst, T., and Volkow, N. (2007). Structural and metabolic
brain changes in the striatum associated with methamphetamine abuse.
Addiction 102(Suppl. 1), 16–32. doi: 10.1111/j.1360-0443.2006.01782.x
Chaouloff, F., Kulikov, A., Sarrieau, A., Castanon, N., and Mormède, P.
(1995). Male Fischer 344 and Lewis rats display differences in locomotor
reactivity, but not in anxiety-related behaviours: relationship with the
hippocampal serotonergic system. Brain Res. 693, 169–178. doi: 10.1016/0006-
8993(95)00733-7
Chen, J. P., Paredes, W., Lowinson, J. H., and Gardner, E. L. (1991). Strain-specific
facilitation of dopamine eﬄux by delta 9-tetrahydrocannabinol in the nucleus
accumbens of rat: an in vivo microdialysis study. Neurosci. Lett. 129, 136–180.
doi: 10.1016/0304-3940(91)90739-G
Chen, H., Hiler, K. A., Tolley, E. A., Matta, S. G., and Sharp, B. M. (2012). Genetic
factors control nicotine self-administration in isogenic adolescent rat strains.
PLoS ONE 7:e44234. doi: 10.1371/journal.pone.0044234
Christensen, C. J., Kohut, S. J., Handler, S., Silberberg, A., and Riley, A. L. (2009).
Demand for food and cocaine in Fischer and Lewis rats. Behav. Neurosci. 123,
165–171. doi: 10.1037/a0013736
Clarke, T. K., Bloch, P. J., Ambrose-Lanci, L. M., Ferraro, T. N., Berrettini,
W. H., Kampman, K. M., et al. (2013). Further evidence for association of
polymorphisms in the CNR1 gene with cocaine addiction: confirmation in
an independent sample and meta-analysis. Addict. Biol. 18, 702–708. doi:
10.1111/j.1369-1600.2011.00346.x
Cohen, H., Zohar, J., Gidron, Y., Matar, M. A., Belkind, D., Loewenthal, U.,
et al. (2006). Blunted HPA axis response to stress influences susceptibility
to posttraumatic stress response in rats. Biol. Psychiatry 59, 1208–1218. doi:
10.1016/j.biopsych.2005.12.003
Cole, B. J., Cador, M., Stinus, L., Rivier, C., Rivier, J., Vale, W., et al. (1990).
Critical role of the hypothalamic pituitary adrenal axis in amphetamine-
induced sensitization of behavior. Life Sci. 47, 1715–1720. doi: 10.1016/0024-
3205(90)90344-Q
Comings, D. E., and Blum, K. (2000). Reward deficiency syndrome: genetic aspects
of behavioral disorders. Prog. Brain Res. 126, 325–341. doi: 10.1016/s0079-
6123(00)26022-6
Coria, S. M., Roura-Martínez, D., Ucha, M., Assis, M. A., Miguéns, M.,
García-Lecumberri, C., et al. (2014). Strain differences in the expression of
endocannabinoid genes and in cannabinoid receptor binding in the brain of
Lewis and Fischer 344 rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 53,
15–22. doi: 10.1016/j.pnpbp.2014.02.012
Crabbe, J. C. (2002). Genetic contributions to addiction. Annu. Rev. Psychol. 53,
435–462. doi: 10.1146/annurev.psych.53.100901.135142
Crews, F. T., Zou, J., and Qin, L. (2011). Induction of innate immune genes in
brain create the neurobiology of addiction. Brain Behav. Immun. 25(Suppl. 1),
S4–S12. doi: 10.1016/j.bbi.2011.03.003
Frontiers in Neuroscience | www.frontiersin.org 16 February 2016 | Volume 10 | Article 13
Cadoni Modeling Genetic Vulnerability to Addiction
Cui, C., Shurtleff, D., and Harris, R. A. (2014). Neuroimmune mechanisms of
alcohol and drug addiction. Int. Rev. Neurobiol. 118, 1–12. doi: 10.1016/B978-
0-12-801284-0.00001-4
Dalley, J. W., Fryer, T. D., Brichard, L., Robinson, E. S., Theobald, D. E., Lääne, K.,
et al. (2007). Nucleus accumbens D2/3 receptors predict trait impulsivity and
cocaine reinforcement. Science 315, 1267–1270. doi: 10.1126/science.1137073
Davis, C. M., Roma, P. G., Dominguez, J. M., and Riley, A. L. (2007). Morphine-
induced place conditioning in Fischer and Lewis rats: acquisition and dose-
response in a fully biased procedure. Pharmacol. Biochem. Behav. 86, 516–523.
doi: 10.1016/j.pbb.2007.01.013
Demers, C. H., Bogdan, R., and Agrawal, A. (2014). The genetics, neurogenetics
and pharmacogenetics of addiction. Curr. Behav. Neurosci. Rep. 1, 33–44. doi:
10.1007/s40473-013-0004-8
Deroche, V., Marinelli, M., Maccari, S., Le Moal, M., Simon, H., and Piazza,
P. V. (1995). Stress-induced sensitization and glucocorticoids. I. Sensitization
of dopamine-dependent locomotor effects of amphetamine and morphine
depends on stress-induced corticosterone secretion. J. Neurosci. 15, 7181–7188.
Deutsch-Feldman, M., Picetti, R., Seip-Cammack, K., Zhou, Y., and Kreek, M. J.
(2015). Effects of handling and vehicle injections on adrenocorticotropic and
corticosterone concentrations in Sprague-Dawley compared with Lewis rats.
J. Am. Assoc. Lab. Anim. Sci. 54, 35–39.
Devine, D. P., Leone, P., and Wise, R. A. (1993). Mesolimbic dopamine
neurotransmission is increased by administration of mu-opioid receptor
antagonists. Eur. J. Pharmacol. 243, 55–64. doi: 10.1016/0014-2999(93)90167-G
Dhabhar, F. S., McEwen, B. S., and Spencer, R. L. (1993). Stress response, adrenal
steroid receptor levels and corticosteroid-binding globulin levels–a comparison
between Sprague-Dawley, Fischer 344 and Lewis rats. Brain Res. 616, 89–98.
doi: 10.1016/0006-8993(93)90196-T
Dhabhar, F. S., McEwen, B. S., and Spencer, R. L. (1997). Adaptation to
prolonged or repeated stress–comparison between rat strains showing intrinsic
differences in reactivity to acute stress. Neuroendocrinology 65, 360–368. doi:
10.1159/000127196
Dhabhar, F. S., Miller, A. H., McEwen, B. S., and Spencer, R. L. (1995). Differential
activation of adrenal steroid receptors in neural and immune tissues of
Sprague Dawley, Fischer 344, and Lewis rats. J. Neuroimmunol. 56, 77–90. doi:
10.1016/0165-5728(94)00135-B
Di Chiara, G. (1998). A motivational learning hypothesis of the role of mesolimbic
dopamine in compulsive drug use. J. Psychopharmacol. 12, 54–67. doi:
10.1177/026988119801200108
Di Chiara, G. (2002). Nucleus accumbens shell and core dopamine: differential role
in behavior and addiction. Behav. Brain Res. 137, 75–114. doi: 10.1016/S0166-
4328(02)00286-3
Di Chiara, G., and Bassareo, V. (2007). Reward system and addiction: what
dopamine does and doesn’t do. Curr. Opin. Pharmacol. 7, 69–76. doi:
10.1016/j.coph.2006.11.003
Di Chiara, G., Bassareo, V., Fenu, S., De Luca, M. A., Spina, L., Cadoni,
C., et al. (2004). Dopamine and drug addiction: the nucleus accumbens
shell connection. Neuropharmacology 47(Suppl. 1), 227–241. doi:
10.1016/j.neuropharm.2004.06.032
Di Chiara, G., Cadoni, C., Lecca, D., and Fenu, S. (2013). Adolescent Cannabis
exposure differentially affects heroin reinforcement and accumbens dopamine
transmission in Lewis and Fischer344 rats. Neuropsychopharmacology 38,
S550–S551.
Di Chiara, G., and Imperato, A. (1988). Opposite effects of mu and kappa opiate
agonists on dopamine release in the nucleus accumbens and in the dorsal
caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244, 1067–1080.
Dick, D. M., Agrawal, A., Keller, M. C., Adkins, A., Aliev, F., Monroe,
S., et al. (2015). Candidate gene-environment interaction research:
reflections and recommendations. Perspect. Psychol. Sci. 10, 37–59. doi:
10.1177/1745691614556682
Elenkov, I. J., Kvetnansky, R., Hashiramoto, A., Bakalov, V. K., Link, A. A.,
Zachman, K., et al. (2008). Low- versus high-baseline epinephrine output
shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like
neurohormonal immune phenotypes in humans? J. Immunol. 181, 1737–1745.
doi: 10.4049/jimmunol.181.3.1737
Ergang, P., KuŽelová, A., Soták, M., Klusoòová, P., Makal, J., and Pácha, J. (2014).
Distinct effect of stress on 11beta-hydroxysteroid dehydrogenase type 1 and
corticosteroid receptors in dorsal and ventral hippocampus. Physiol. Res. 63,
255–261.
Ergang, P., Vodicˇka, M., Soták, M., Klusonˇová, P., Behuliak, M., Rˇeháková, L., et al.
(2015). Differential impact of stress on hypothalamic-pituitary-adrenal axis:
gene expression changes in Lewis and Fisher rats. Psychoneuroendocrinology
53, 49–59. doi: 10.1016/j.psyneuen.2014.12.013
Evans, B. E., Greaves-Lord, K., Euser, A. S., Franken, I. H., and Huizink,
A. C. (2012). The relation between hypothalamic-pituitary-adrenal (HPA)
axis activity and age of onset of alcohol use. Addiction 107, 312–322. doi:
10.1111/j.1360-0443.2011.03568.x
Everitt, B. J., Dickinson, A., and Robbins, T. W. (2001). The neuropsychological
basis of addictive behaviour. Brain Res. Brain Res. Rev. 36, 129–138. doi:
10.1016/S0165-0173(01)00088-1
Everitt, B. J., and Robbins, T. W. (2013). From the ventral to the dorsal striatum:
devolving views of their roles in drug addiction. Neurosci. Biobehav. Rev. 37,
1946–1954. doi: 10.1016/j.neubiorev.2013.02.010
Faris, P. L., Komisaruk, B. R., Watkins, L. R., and Mayer, D. J. (1983). Evidence for
the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science
219, 310–312. doi: 10.1126/science.6294831
Fenu, S., Spina, L., Rivas, E., Longoni, R., and Di Chiara, G. (2006). Morphine-
conditioned single-trial place preference: role of nucleus accumbens shell
dopamine receptors in acquisition, but not expression. Psychopharmacology
187, 143–153. doi: 10.1007/s00213-006-0415-2
Fernandez, F., Porras, G., Mormède, P., Spampinato, U., and Chaouloff, F. (2003a).
Effects of 3,4-methylenedioxymethamphetamine on locomotor activity and
extracellular dopamine in the nucleus accumbens of Fischer 344 and Lewis rats.
Neurosci. Lett. 335, 212–216. doi: 10.1016/S0304-3940(02)01180-1
Fernandez, F., Sarre, S., Launay, J. M., Aguerre, S., Guyonnet-Dupérat, V., Moisan,
M. P., et al. (2003b). Rat strain differences in peripheral and central serotonin
transporter protein expression and function. Eur. J. Neurosci. 17, 494–506. doi:
10.1046/j.1460-9568.2003.02473.x
File, S. E. (1991). “The Biological basis of anxiety,” in Current Practices and Future
Development in Pharmacotherapy for Mental Disorders, eds H. Y. Meltzer and
D. Nerozi (Amsterdam: Elsevier), 159–165.
Flatscher-Bader, T., Zuvela, N., Landis, N., and Wilce, P. A. (2008). Smoking and
alcoholism target genes associated with plasticity and glutamate transmission
in the human ventral tegmental area. Hum. Mol. Genet. 17, 38–51. doi:
10.1093/hmg/ddm283
Flores, G., Wood, G. K., Barbeau, D., Quirion, R., and Srivastava, L. K. (1998).
Lewis and Fischer rats: a comparison of dopamine transporter and receptors
levels. Brain Res. 814, 34–40. doi: 10.1016/S0006-8993(98)01011-7
Fole, A., González-Martín, C., Huarte, C., Alguacil, L. F., Ambrosio, E., and Del
Olmo, N. (2011). Effects of chronic cocaine administration on spatial learning
and hippocampal spine density in two genetically different strains of rats.
Neurobiol. Learn. Mem. 95, 491–497. doi: 10.1016/j.nlm.2011.02.012
Fole, A., Martin, M., Morales, L., and Del Olmo, N. (2015). Effects of
chronic cocaine treatment during adolescence in Lewis and Fischer-344
rats: novel location recognition impairment and changes in synaptic
plasticity in adulthood. Neurobiol. Learn. Mem. 123, 179–186. doi:
10.1016/j.nlm.2015.06.001
Fox, H. C., Jackson, E. D., and Sinha, R. (2009). Elevated cortisol and learning
and memory deficits in cocaine dependent individuals: relationship
to relapse outcomes. Psychoneuroendocrinology 34, 1198–1207. doi:
10.1016/j.psyneuen.2009.03.007
Freeman, K. B., Kearns, D. N., Kohut, S. J., and Riley, A. L. (2009).
Strain differences in patterns of drug-intake during prolonged access to
cocaine self-administration. Behav. Neurosci. 123, 156–164. doi: 10.1037/a0
013727
Fuchs, R. A., Branham, R. K., and See, R. E. (2006). Different neural substrates
mediate cocaine seeking after abstinence versus extinction training: a critical
role for the dorsolateral caudate-putamen. J. Neurosci. 26, 3584–3588. doi:
10.1523/JNEUROSCI.5146-05.2006
Gallagher, P., Reid, K. S., and Ferrier, I. N. (2009). Neuropsychological
functioning in health and mood disorder: modulation by glucocorticoids
and their receptors. Psychoneuroendocrinology 34(Suppl. 1), S196–S207. doi:
10.1016/j.psyneuen.2009.05.018
García-Lecumberri, C., Torres, I., Martín, S., Crespo, J. A., Miguéns, M.,
Nicanor, C., et al. (2011). Strain differences in the dose-response relationship
for morphine self-administration and impulsive choice between Lewis and
Fischer 344 rats. J. Psychopharmacol. 25, 783–791. doi: 10.1177/0269881110
367444
Frontiers in Neuroscience | www.frontiersin.org 17 February 2016 | Volume 10 | Article 13
Cadoni Modeling Genetic Vulnerability to Addiction
George, F. R. (1987). Genetic and environmental factors in ethanol self-
administration. Pharmacol. Biochem. Behav. 27, 379–384. doi: 10.1016/0091-
3057(87)90586-7
Ghitza, U. E., Preston, K. L., Epstein, D. H., Kuwabara, H., Endres, C. J., Bencherif,
B., et al. (2010). Brain mu-opioid receptor binding predicts treatment
outcome in cocaine-abusing outpatients. Biol. Psychiatry 68, 697–703. doi:
10.1016/j.biopsych.2010.05.003
Goeders, N. E., Guerin, G. F., and Schmoutz, C. D. (2014). The combination
of metyrapone and oxazepam for the treatment of cocaine and other drug
addictions. Adv. Pharmacol. 69, 419–479. doi: 10.1016/B978-0-12-420118-
7.00011-1
Gómez, F., De Kloet, E. R., and Armario, A. (1998). Glucocorticoid negative
feedback on the HPA axis in five inbred rat strains. Am. J. Physiol. 274,
R420–R427.
Gómez, F., Lahmame, A., de Kloet, E. R., and Armario, A. (1996). Hypothalamic-
pituitary-adrenal response to chronic stress in five inbred rat strains: differential
responses aremainly located at the adrenocortical level.Neuroendocrinology 63,
327–337. doi: 10.1159/000126973
Gorelick, D. A., Kim, Y. K., Bencherif, B., Boyd, S. J., Nelson, R., Copersino, M.
L., et al. (2008). Brain mu-opioid receptor binding: relationship to relapse to
cocaine use after monitored abstinence. Psychopharmacology 200, 475–486. doi:
10.1007/s00213-008-1225-5
Gorwood, P., Le Strat, Y., Ramoz, N., Dubertret, C., Moalic, J. M., and Simonneau,
M. (2012). Genetics of dopamine receptors and drug addiction. Hum. Genet.
131, 803–822. doi: 10.1007/s00439-012-1145-7
Graf, E. N., Wheeler, R. A., Baker, D. A., Ebben, A. L., Hill, J. E., McReynolds,
J. R., et al. (2013). Corticosterone acts in the nucleus accumbens to
enhance dopamine signaling and potentiate reinstatement of cocaine seeking.
J. Neurosci. 33, 11800–11810. doi: 10.1523/JNEUROSCI.1969-13.2013
Grakalic, I., Schindler, C. W., Baumann, M. H., Rice, K. C., and Riley, A. L.
(2006). Effects of stress modulation on morphine-induced conditioned place
preferences and plasma corticosterone levels in Fischer, Lewis, and Sprague-
Dawley rat strains. Psychopharmacology 189, 277–286. doi: 10.1007/s00213-
006-0562-5
Griffin, A. C., andWhitacre, C. C. (1991). Sex and strain differences in the circadian
rhythm fluctuation of endocrine and immune function in the rat: implications
for rodent models of autoimmune disease. J. Neuroimmunol. 35, 53–64. doi:
10.1016/0165-5728(91)90161-Y
Grota, L. J., Bienen, T., and Felten, D. L. (1997). Corticosterone responses of
adult Lewis and Fischer rats. J. Neuroimmunol. 74, 95–101. doi: 10.1016/S0165-
5728(96)00209-3
Gulley, J. M., Everett, C. V., and Zahniser, N. R. (2007). Inbred Lewis and Fischer
344 rat strains differ not only in novelty- and amphetamine-induced behaviors,
but also in dopamine transporter activity in vivo. Brain Res. 1151, 32–45. doi:
10.1016/j.brainres.2007.03.009
Guitart, X., Beitner-Johnson, D., Marby, D. W., Kosten, T. A., and Nestler, E. J.
(1992). Fischer and Lewis rat strains differ in basal levels of neurofilament
proteins and their regulation by chronicmorphine in themesolimbic dopamine
system. Synapse 12, 242–253. doi: 10.1002/syn.890120310
Guitart, X., Kogan, J. H., Berhow, M., Terwilliger, R. Z., Aghajanian, G.
K., and Nestler, E. J. (1993). Lewis and Fischer rat strains display
differences in biochemical, electrophysiological and behavioral parameters:
studies in the nucleus accumbens and locus coeruleus of drug naive and
morphine-treated animals. Brain Res. 611, 7–17. doi: 10.1016/0006-8993(93)
91770-S
Haile, C. N., Hiroi, N., Nestler, E. J., and Kosten, T. A. (2001). Differential
behavioral responses to cocaine are associated with dynamics of mesolimbic
dopamine proteins in Lewis and Fischer 344 rats. Synapse 41, 179–190. doi:
10.1002/syn.1073
Hall, F. S., Drgonova, J., Jain, S., and Uhl, G. R. (2013). Implications of
genome wide association studies for addiction: are our a priori assumptions
all wrong? Pharmacol. Ther. 140, 267–279. doi: 10.1016/j.pharmthera.2013.
07.006
Hamilton, K. R., Potenza, M. N., and Grunberg, N. E. (2014). Lewis rats have
greater response impulsivity than Fischer rats. Addict. Behav. 39, 1565–1572.
doi: 10.1016/j.addbeh.2014.02.008
Harkany, T., Keimpema, E., Barabás, K., and Mulder, J. (2008). Endocannabinoid
functions controlling neuronal specification during brain development. Mol.
Cell. Endocrinol. 286(Suppl. 1), S84–S90. doi: 10.1016/j.mce.2008.02.011
Harris, H. W., and Nestler, E. J. (1996). Immunohistochemical studies of
mesolimbic dopaminergic neurons in Fischer 344 and Lewis rats. Brain Res.
706, 1–12. doi: 10.1016/0006-8993(95)01088-2
Hayes, D. J., Jupp, B., Sawiak, S. J., Merlo, E., Caprioli, D., and Dalley, J. W. (2014).
Brain γ-aminobutyric acid: a neglected role in impulsivity. Eur. J. Neurosci. 39,
1921–1932. doi: 10.1111/ejn.12485
Hensleigh, E., and Pritchard, L. M. (2013). Glucocorticoid receptor expression and
sub-cellular localization in dopamine neurons of the rat midbrain. Neurosci.
Lett. 556, 191–195. doi: 10.1016/j.neulet.2013.09.067
Herradón, G., Ezquerra, L., Morales, L., Franklin, B., Silos-Santiago, I., and
Alguacil, L. F. (2006). Lewis and Fischer 344 strain differences in alpha2-
adrenoceptors and tyrosine hydroxylase expression. Life Sci. 78, 862–868. doi:
10.1016/j.lfs.2005.05.093
Herradón, G., Morales, L., and Alguacil, L. F. (2003). Differences of mu-
opioid receptors between Lewis and F344 rats. Life Sci. 73, 1537–1542. doi:
10.1016/S0024-3205(03)00479-X
Higuera-Matas, A., Montoya, G. L., Coria, S. M., Miguéns, M., García-
Lecumberri, C., and Ambrosio, E. (2011). Differential gene expression
in the nucleus accumbens and frontal cortex of Lewis and Fischer 344
rats relevant to drug addiction. Curr. Neuropharmacol. 9, 143–150. doi:
10.2174/157015911795017290
Hökfelt, T., Rehfeld, J. F., Skirboll, L., Ivemark, B., Goldstein, M., and Markey,
K. (1980). Evidence for coexistence of dopamine and CCK in meso-limbic
neurones. Nature 285, 476–478. doi: 10.1038/285476a0
Horan, B., Smith, M., Gardner, E. L., Lepore, M., and Ashby, C. R. Jr. (1997). (-)-
Nicotine produces conditioned place preference in Lewis, but not Fischer 344
rats. Synapse 26, 93–94.
Horvath, M. C., Kovacs, G. G., Kovari, V., Majtenyi, K., Hurd, Y. L., and Keller,
E. (2007). Heroin abuse is characterized by discrete mesolimbic dopamine and
opioid abnormalities and exaggerated nuclear receptor-related 1 transcriptional
decline with age. J. Neurosci. 27, 13371–13375. doi: 10.1523/JNEUROSCI.2398-
07.2007
Huskinson, S. L., and Anderson, K. G. (2012). Effects of acute and chronic
administration of diazepam on delay discounting in Lewis and Fischer 344 rats.
Behav. Pharmacol. 23, 315–330. doi: 10.1097/FBP.0b013e3283564da4
Huskinson, S. L., Krebs, C. A., and Anderson, K. G. (2012). Strain differences in
delay discounting between Lewis and Fischer 344 rats at baseline and following
acute and chronic administration of d-amphetamine. Pharmacol. Biochem.
Behav. 101, 403–416. doi: 10.1016/j.pbb.2012.02.005
Huston, J. P., Silva, M. A., Topic, B., and Müller, C. P. (2013). What’s conditioned
in conditioned place preference? Trends Pharmacol. Sci. 34, 162–166. doi:
10.1016/j.tips.2013.01.004
Ikemoto, S. (2007). Dopamine reward circuitry: two projection systems from the
ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain
Res. Rev. 56, 27–78. doi: 10.1016/j.brainresrev.2007.05.004
Ito, R., and Hayen, A. (2011). Opposing roles of nucleus accumbens core and shell
dopamine in the modulation of limbic information processing. J. Neurosci. 31,
6001–6007. doi: 10.1523/JNEUROSCI.6588-10.2011
Jupp, B., Caprioli, D., Saigal, N., Reverte, I., Shrestha, S., Cumming, P., et al.
(2013). Dopaminergic and GABA-ergic markers of impulsivity in rats: evidence
for anatomical localisation in ventral striatum and prefrontal cortex. Eur. J.
Neurosci. 37, 1519–1528. doi: 10.1111/ejn.12146
Jupp, B., and Dalley, J. W. (2014). Convergent pharmacological mechanisms in
impulsivity and addiction: insights from rodent models. Br. J. Pharmacol. 171,
4729–4766. doi: 10.1111/bph.12787
Kalivas, P. W., and Stewart, J. (1995). Dopamine transmission in the initiation and
expression of drug- and stress-induced sensitization of motor activity. Brain
Res. Brain. Res Rev. 16, 223–244. doi: 10.1016/0165-0173(91)90007-U
Kasanetz, F., Deroche-Gamonet, V., Berson, N., Balado, E., Lafourcade, M.,
Manzoni, O., et al. (2010). Transition to addiction is associated with a
persistent impairment in synaptic plasticity. Science 328, 1709–1712. doi:
10.1126/science.1187801
Kearns, D. N., Gomez-Serrano, M. A., Weiss, S. J., and Riley, A. L. (2006). A
comparison of Lewis and Fischer rat strains on autoshaping (sign-tracking),
discrimination reversal learning and negative auto-maintenance. Behav. Brain
Res. 169, 193–200. doi: 10.1016/j.bbr.2006.01.005
Kendler, K. S., Chen, X., Dick, D., Maes, H., Gillespie, N., Neale, M. C., et al.
(2012). Recent advances in the genetic epidemiology and molecular genetics
of substance use disorders. Nat. Neurosci. 15, 181–189. doi: 10.1038/nn.3018
Frontiers in Neuroscience | www.frontiersin.org 18 February 2016 | Volume 10 | Article 13
Cadoni Modeling Genetic Vulnerability to Addiction
Kendler, K. S., and Eaves, L. J. (1986). Models for the joint effect of genotype and
environment on liability to psychiatric illness. Am. J. Psychiatry 143, 279–289.
doi: 10.1176/ajp.143.3.279
Kendler, K. S., Neale, M. C., Sullivan, P., Corey, L. A., Gardner, C. O.,
and Prescott, C. A. (1999). A population based twin study in women of
smoking initiation and nicotine dependence. Psychol. Med. 29, 299–308. doi:
10.1017/S0033291798008022
Kish, S. J., Kalasinsky, K. S., Derkach, P., Schmunk, G. A., Guttman, M., Ang,
L., et al. (2001). Striatal dopaminergic and serotonergic markers in human
heroin users. Neuropsychopharmacology 24, 561–567. doi: 10.1016/S0893-
133X(00)00209-8
Kobrin, K. L., Moody, O., Arena, D. T., Moore, C. F., Heinrichs, S. C., and Kaplan,
G. B. (2015). Acquisition of morphine conditioned place preference increases
the dendritic complexity of nucleus accumbens core neurons. Addict. Biol. doi:
10.1111/adb.12273. [Epub ahead of print].
Koob, G. F. (2006). The neurobiology of addiction: a neuroadaptational view
relevant for diagnosis. Addiction 101(Suppl. 1), 23–30. doi: 10.1111/j.1360-
0443.2006.01586.x
Koob, G. F. (2009). Brain stress systems in the amygdala and addiction. Brain Res.
1293, 61–75. doi: 10.1016/j.brainres.2009.03.038
Koob, G. F. (2013). Negative reinforcement in drug addiction: the darkness within.
Curr. Opin. Neurobiol. 23, 559–563. doi: 10.1016/j.conb.2013.03.011
Koob, G. F. (2015). The dark side of emotion: the addiction perpective. Eur. J.
Pharmacol. 753, 73–87. doi: 10.1016/j.ejphar.2014.11.044
Koob, G. F., and Kreek,M. J. (2007). Stress, dysregulation of drug reward pathways,
and the transition to drug dependence. Am. J. Psychiatry 164, 1149–1159. doi:
10.1176/appi.ajp.2007.05030503
Kornetsky, C., and Bain, G. (1992). Brain-stimulation reward: amodel for the study
of the rewarding effects of abused drugs. NIDA Res. Monogr. 124, 73–93.
Kosten, T. A., and Ambrosio, E. (2002). HPA axis function and drug addictive
behaviors: insights from studies with Lewis and Fischer 344 inbred rats.
Psychoneuroendocrinology 27, 35–69. doi: 10.1016/S0306-4530(01)00035-X
Kosten, T. A., and Miserendino, M. J. (2012). Stress alters the discriminative
stimulus and response rate effects of cocaine differentially in Lewis and Fischer
inbred rats. Behav. Sci. (Basel) 2, 23–37. doi: 10.3390/bs2010023
Kosten, T. A., Miserendino, M. J., Chi, S., and Nestler, E. J. (1994). Fischer
and Lewis rat strains show differential cocaine effects in conditioned place
preference and behavioral sensitization but not in locomotor activity or
conditioned taste aversion. J. Pharmacol. Exp. Ther. 269, 137–144.
Kosten, T. A., Miserendino, M. J., Haile, C. N., DeCaprio, J. L., Jatlow, P. I., and
Nestler, E. J. (1997). Acquisition and maintenance of intravenous cocaine self-
administration in Lewis and Fischer inbred rat strains. Brain Res. 778, 418–429.
doi: 10.1016/S0006-8993(97)01205-5
Kosten, T. A., Zhang, X. Y., and Haile, C. N. (2007). Strain differences
in maintenance of cocaine self-administration and their relationship to
novelty activity responses. Behav. Neurosci. 121, 380–388. doi: 10.1037/0735-
7044.121.2.380
Kranz, G. S., Kasper, S., and Lanzenberger, R. (2010). Reward and the serotonergic
system. Neuroscience 166, 1023–1035. doi: 10.1016/j.neuroscience.2010.
01.036
Kruzich, P. J., and Xi, J. (2006a). Different patterns of pharmacological
reinstatement of cocaine-seeking behavior between Fischer 344 and Lewis rats.
Psychopharmacology 187, 22–29. doi: 10.1007/s00213-005-0264-4
Kruzich, P. J., and Xi, J. (2006b). Differences in extinction responding and
reinstatement of methamphetamine-seeking behavior between Fischer
344 and Lewis rats. Pharmacol. Biochem. Behav. 83, 391–395. doi:
10.1016/j.pbb.2006.02.021
Kulikov, A., Aguerre, S., Berton, O., Ramos, A., Mormede, P., and Chaouloff,
F. (1997). Central serotonergic systems in the spontaneously hypertensive
and Lewis rat strains that differ in the elevated plus-maze test of anxiety.
J. Pharmacol. Exp. Ther. 281, 775–784.
Ladurelle, N., Keller, G., Roques, B. P., and Daugé, V. (1993). Effects of CCK8
and of the CCKB-selective agonist BC264 on extracellular dopamine content
in the anterior and posterior nucleus accumbens: a microdialysis study in
freely moving rats. Brain Res. 628, 254–262. doi: 10.1016/0006-8993(93)
90962-M
Lamprecht, R., and LeDoux, J. (2004). Structural plasticity and memory. Nat. Rev.
Neurosci. 5, 45–54. doi: 10.1038/nrn1301
Le Foll, B., Gallo, A., Le Strat, Y., Lu, L., and Gorwood, P. (2009). Genetics
of dopamine receptors and drug addiction: a comprehensive review. Behav.
Pharmacol. 20, 1–17. doi: 10.1097/FBP.0b013e3283242f05
Lepore, M., Liu, X., Savage, V., Matalon, D., and Gardner, E. L. (1996).
Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of
brain stimulation reward as measured by a rate-frequency curve-shift electrical
brain stimulation paradigm in three different rat strains. Life Sci. 58, PL365–
PL372. doi: 10.1016/0024-3205(96)00237-8
Leroy, C., Karila, L., Martinot, J. L., Lukasiewicz, M., Duchesnay, E., Comtat, C.,
et al. (2012). Striatal and extrastriatal dopamine transporter in cannabis and
tobacco addiction: a high-resolution PET study. Addict. Biol. 17, 981–990. doi:
10.1111/j.1369-1600.2011.00356.x
Li, C. Y., Mao, X., and Wei, L. (2008). Genes and (common) pathways underlying
drug addiction. PLoS Comput. Biol. 4:e2. doi: 10.1371/journal.pcbi.0040002
Li, Y. Q., Xue, Y. X., He, Y. Y., Li, F. Q., Xue, L. F., Xu, C. M., et al. (2011).
Inhibition of PKMzeta in nucleus accumbens core abolishes long-term drug
reward memory. J. Neurosci. 31, 5436–5446. doi: 10.1523/JNEUROSCI.5884-
10.2011
Lovallo, W. R. (2006). Cortisol secretion patterns in addiction and addiction risk.
Int. J. Psychophysiol. 59, 195–202. doi: 10.1016/j.ijpsycho.2005.10.007
Macho, L., Rovensky, J., Kvetnansky, R., Radikova, Z., Fickova, M., and Zorad, S.
(2008). Hormone response to stress in rat strains of different susceptibility to
immunologic challenge. Endocr. Regul. 42, 23–28.
Madden, G. J., Smith, N. G., Brewer, A. T., Pinkston, J. W., and Johnson, P. S.
(2008). Steady-state assessment of impulsive choice in Lewis and Fischer 344
rats: between-condition delay manipulations. J. Exp. Anal. Behav. 90, 333–344.
doi: 10.1901/jeab.2008.90-333
Maes, H. H., Sullivan, P. F., Bulik, C. M., Neale, M. C., Prescott, C. A., Eaves,
L. J., et al. (2004). A twin study of genetic and environmental influences on
tobacco initiation, regular tobacco use and nicotine dependence. Psychol. Med.
34, 1251–1261. doi: 10.1017/S0033291704002405
Marinelli, M., Aouizerate, B., Barrot, M., Le Moal, M., and Piazza, P.
V. (1998). Dopamine-dependent responses to morphine depend on
glucocorticoid receptors. Proc. Natl. Acad. Sci. U.S.A. 95, 7742–7747. doi:
10.1073/pnas.95.13.7742
Marinelli, M., Piazza, P. V., Deroche, V., Maccari, S., Le Moal, M., and Simon, H.
(1994). Corticosterone circadian secretion differentially facilitates dopamine-
mediated psychomotor effect of cocaine and morphine. J. Neurosci. 14,
2724–2731.
Markou, A., and Koob, G. F. (1993). “Intracranial self-stimulation thresholds as a
measure of reward,” in Behavioural Neuroscience: A Practical Approach, ed A.
Sahgal (Oxford; New York, NY: University Press), 93–115.
Martín, S., Lyupina, Y., Crespo, J. A., González, B., García-Lecumberri, C., and
Ambrosio, E. (2003). Genetic differences in NMDA and D1 receptor levels, and
operant responding for food and morphine in Lewis and Fischer 344 rats. Brain
Res. 973, 205–213. doi: 10.1016/S0006-8993(03)02482-X
Martín, S., Manzanares, J., Corchero, J., García-Lecumberri, C., Crespo, J. A.,
Fuentes, J. A., et al. (1999). Differential basal proenkephalin gene expression
in dorsal striatum and nucleus accumbens, and vulnerability to morphine self-
administration in Fischer 344 and Lewis rats. Brain Res. 821, 350–355. doi:
10.1016/S0006-8993(99)01122-1
Mayo-Michelson, L., and Young, G. A. (1992). Effects of chronic morphine
administration and naloxone on EEG, EEG power spectra, and associated
behavior in two inbred rat strains. Pharmacol. Biochem. Behav. 42, 815–821.
doi: 10.1016/0091-3057(92)90035-E
McKee, S. A., Sinha, R., Weinberger, A. H., Sofuoglu, M., Harrison, E. L.,
Lavery, M., et al. (2011). Stress decreases the ability to resist smoking and
potentiates smoking intensity and reward. J. Psychopharmacol. 25, 490–502.
doi: 10.1177/0269881110376694
Melis, M., and Pistis, M. (2012). Hub and switches: endocannabinoid signalling
in midbrain dopamine neurons. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 367,
3276–3285. doi: 10.1098/rstb.2011.0383
Meyer, A. C., and Bardo, M. T. (2015). Amphetamine self-administration
and dopamine function: assessment of gene × environment interactions
in Lewis and Fischer 344 rats. Psychopharmacology 232, 2275–2285. doi:
10.1007/s00213-014-3854-1
Meyer, A. C., Rahman, S., Charnigo, R. J., Dwoskin, L. P., Crabbe, J. C., and Bardo,
M. T. (2010). Genetics of novelty seeking, amphetamine self-administration
Frontiers in Neuroscience | www.frontiersin.org 19 February 2016 | Volume 10 | Article 13
Cadoni Modeling Genetic Vulnerability to Addiction
and reinstatement using inbred rats. Genes Brain Behav. 9, 790–798. doi:
10.1111/j.1601-183X.2010.00616.x
Miguéns, M., Botreau, F., Olías, O., Del Olmo, N., Coria, S. M., Higuera-Matas, A.,
et al. (2013). Genetic differences in the modulation of accumbal glutamate and
γ-amino butyric acid levels after cocaine-induced reinstatement. Addict. Biol.
18, 623–632. doi: 10.1111/j.1369-1600.2011.00404.x
Miguéns, M., Coria, S. M., Higuera-Matas, A., Fole, A., Ambrosio, E.,
and Del Olmo, N. (2011). Depotentiation of hippocampal long-
term potentiation depends on genetic background and is modulated
by cocaine self-administration. Neuroscience 187, 36–42. doi:
10.1016/j.neuroscience.2011.04.056
Millan, E. Z., Marchant, N. J., and McNally, G. P. (2011). Extinction of drug
seeking. Behav. Brain Res. 217, 454–462. doi: 10.1016/j.bbr.2010.10.037
Minabe, Y., Emori, K., and Ashby, C. R. Jr. (1995). Significant differences in the
activity of midbrain dopamine neurons between male Fischer 344 (F344) and
Lewis rats: an in vivo electrophysiological study. Life Sci. 56, PL261–PL267. doi:
10.1016/0024-3205(95)00075-5
Mocsary, Z., and Bradberry, C. W. (1996). Effect of ethanol on extracellular
dopamine in nucleus accumbens: comparison between Lewis and Fischer 344
rat strains. Brain Res. 706, 194–198. doi: 10.1016/0006-8993(95)01200-1
Moncek, F., Kvetnansky, R., and Jezova, D. (2001). Differential responses to stress
stimuli of Lewis and Fischer rats at the pituitary and adrenocortical level.
Endocr. Regul. 35, 35–41.
Monterosso, J., and Ainslie, G. (1999). Beyond discounting: possible experimental
models of impulse control. Psychopharmacology 146, 339–347. doi:
10.1007/PL00005480
Moreno, M., Economidou, D., Mar, A. C., López-Granero, C., Caprioli, D.,
Theobald, D. E., et al. (2013). Divergent effects of D2/3 receptor activation
in the nucleus accumbens core and shell on impulsivity and locomotor
activity in high and low impulsive rats. Psychopharmacology 228, 19–30. doi:
10.1007/s00213-013-3010-3
Neeley, E. W., Berger, R., Koenig, J. I., and Leonard, S. (2011). Prenatal
stress differentially alters brain-derived neurotrophic factor expression
and signaling across rat strains. Neuroscience 187, 24–35. doi:
10.1016/j.neuroscience.2011.03.065
Negus, S. S., and Miller, L. L. (2014). Intracranial self-stimulation to evaluate abuse
potential of drugs. Pharmacol. Rev. 66, 869–917. doi: 10.1124/pr.112.007419
Nestler, E. J. (2001). Molecular basis of long-term plasticity underlying addiction.
Nat. Rev. Neurosci. 2, 119–128. doi: 10.1038/35053570
Noble, E. P. (2000). The DRD2 gene in psychiatric and neurological disorders and
its phenotypes. Pharmacogenomics 1, 309–333. doi: 10.1517/14622416.1.3.309
Noble, F., Benturquia, N., Crete, D., Canestrelli, C., Mas Nieto, M., Wilson, J., et al.
(2012). Relationship between vulnerability to reinforcing effects of morphine
and activity of the endogenous cholecystokinin system in Lewis and Fischer
rats. Addict. Biol. 17, 528–538. doi: 10.1111/j.1369-1600.2010.00283.x
Nylander, I., Vlaskovska, M., and Terenius, L. (1995). Brain dynorphin and
enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and
withdrawal. Brain Res. 683, 25–35. doi: 10.1016/0006-8993(95)00279-Y
Olds, J., and Milner, P. (1954). Positive reinforcement produced by electrical
stimulation of septal area and other regions of the brain. J. Comp. Physiol.
Psychol. 47, 419–427. doi: 10.1037/h0058775
Ottman, R. (1996). Gene-environment interaction: definitions and study designs.
Prev. Med. 25, 764–770. doi: 10.1006/pmed.1996.0117
Panagis, G., Mackey, B., and Vlachou, S. (2014). Cannabinoid regulation of brain
reward processing with an emphasis on the role of CB1 receptors: a step back
into the future. Front. Psychiatry 5:92. doi: 10.3389/fpsyt.2014.00092
Panlilio, L. V., and Goldberg, S. R. (2007). Self-administration of drugs in animals
and humans as a model and an investigative tool. Addiction 102, 1863–1870.
doi: 10.1111/j.1360-0443.2007.02011.x
Paris, J. J., Franco, C., Sodano, R., Frye, C. A., and Wulfert, E. (2010). Gambling
pathology is associated with dampened cortisol response among men and
women. Physiol. Behav. 99, 230–233. doi: 10.1016/j.physbeh.2009.04.002
Philibin, S. D., Vann, R. E., Varvel, S. A., Covington, H. E. III, Rosecrans, J.
A., James, J. R., et al. (2005). Differential behavioral responses to nicotine
in Lewis and Fischer-344 rats. Pharmacol. Biochem. Behav. 80, 87–92. doi:
10.1016/j.pbb.2004.10.009
Piazza, P. V., and Deroche-Gamonet, V. (2013). A multistep general
theory of transition to addiction. Psychopharmacology 229, 387–413. doi:
10.1007/s00213-013-3224-4
Piazza, P. V., and Le Moal, M. L. (1996). Pathophysiological basis of vulnerability
to drug abuse: role of an interaction between stress, glucocorticoids, and
dopaminergic neurons. Annu. Rev. Pharmacol. Toxicol. 36, 359–378. doi:
10.1146/annurev.pa.36.040196.002043
Piazza, P. V., Rougé-Pont, F., Deroche, V., Maccari, S., Simon, H., and Le Moal,
M. (1996). Glucocorticoids have state-dependent stimulant effects on the
mesencephalic dopaminergic transmission. Proc. Natl. Acad. Sci. U.S.A. 93,
8716–8720. doi: 10.1073/pnas.93.16.8716
Picetti, R., Caccavo, J. A., Ho, A., and Kreek, M. J. (2012). Dose escalation and dose
preference in extended-access heroin self-administration in Lewis and Fischer
rats. Psychopharmacology 220, 163–172. doi: 10.1007/s00213-011-2464-4
Picetti, R., Ho, A., Butelman, E. R., and Kreek, M. J. (2010). Dose preference
and dose escalation in extended-access cocaine self-administration in Fischer
and Lewis rats. Psychopharmacology 211, 313–323. doi: 10.1007/s00213-010-
1899-3
Prasad, B. M., Sorg, B. A., Ulibarri, C., and Kalivas, P. W. (1995). Sensitization
to stress and psychostimulants. Involvement of dopamine transmission versus
the HPA axis. Ann. N.Y. Acad. Sci. 771, 617–625. doi: 10.1111/j.1749-
6632.1995.tb44714.x
Proudnikov, D., Kroslak, T., Sipe, J. C., Randesi, M., Li, D., Hamon, S., et al. (2010).
Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty
acid amide hydrolase (FAAH) genes with heroin addiction: impact of long
repeats of CNR1. Pharmacogenomics J. 10, 232–242. doi: 10.1038/tpj.2009.59
Ramos, A., Berton, O., Mormède, P., and Chaouloff, F. (1997). A multiple-test
study of anxiety-related behaviours in six inbred rat strains. Behav. Brain Res.
85, 57–69. doi: 10.1016/S0166-4328(96)00164-7
Ranaldi, R., Bauco, P., McCormick, S., Cools, A. R., and Wise, R. A. (2001). Equal
sensitivity to cocaine reward in addiction-prone and addiction-resistant rat
genotypes. Behav. Pharmacol. 12, 527–534. doi: 10.1097/00008877-200111000-
00014
Ray, L. A., Roche, D. J., Heinzerling, K., and Shoptaw, S. (2014). Opportunities for
the development of neuroimmune therapies in addiction. Int. Rev. Neurobiol.
118, 381–401. doi: 10.1016/B978-0-12-801284-0.00012-9
Ray, L. A., Rhee, S. H., Stallings, M. C., Knopik, V., and Hutchison, K. E. (2007).
Examining the heritability of a laboratory-based smoking endophenotype:
initial results from an experimental twin study. Twin Res. Hum. Genet. 10,
546–553. doi: 10.1375/twin.10.4.546
Reichel, C. M., and Bevins, R. A. (2009). Forced abstinence model of relapse to
study pharmacological treatments of substance use disorder. Curr. Drug Abuse
Rev. 2, 184–194. doi: 10.2174/1874473710902020184
Reul, J. M., and de Kloet, E. R. (1985). Two receptor systems for corticosterone
in rat brain: microdistribution and differential occupation. Endocrinology 117,
2505–2511. doi: 10.1210/endo-117-6-2505
Rex, A., Sondern, U., Voigt, J. P., Franck, S., and Fink, H. (1996). Strain differences
in fear-motivated behavior of rats. Pharmacol. Biochem. Behav. 54, 107–111.
doi: 10.1016/0091-3057(95)02128-0
Reynolds, B. (2006). A review of delay-discounting research with humans:
relations to drug use and gambling. Behav. Pharmacol. 17, 651–667. doi:
10.1097/FBP.0b013e3280115f99
Rivera, P., Miguéns, M., Coria, S. M., Rubio, L., Higuera-Matas, A., Bermúdez-
Silva, F. J., et al. (2013). Cocaine self-administration differentially modulates
the expression of endogenous cannabinoid system-related proteins in the
hippocampus of Lewis vs. Fischer 344 rats. Int. J. Neuropsychopharmacol. 16,
1277–1293. doi: 10.1017/S1461145712001186
Rivest, S., and Rivier, C. (1994). Stress and interleukin-1 beta-induced activation of
c-fos, NGFI-B and CRF gene expression in the hypothalamic PVN: comparison
between Sprague-Dawley, Fisher-344 and Lewis rats. J. Neuroendocrinol. 6,
101–117. doi: 10.1111/j.1365-2826.1994.tb00559.x
Rivet, J. M., Stinus, L., LeMoal, M., and Mormède, P. (1989). Behavioral
sensitization to amphetamine is dependent on corticosteroid receptor
activation. Brain Res. 498, 149–153. doi: 10.1016/0006-8993(89)90411-3
Robinson, T. E., and Berridge, K. C. (2001). Incentive-sensitization and addiction.
Addiction 96, 103–114. doi: 10.1046/j.1360-0443.2001.9611038.x
Robinson, T. E., and Berridge, K. C. (2008). The incentive sensitization theory of
addiction: some current issues. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 363,
3137–3146. doi: 10.1098/rstb.2008.0093
Robinson, T. E., and Kolb, B. (2004). Structural plasticity associated with
exposure to drugs of abuse. Neuropharmacology 47(Suppl. 1), 33–46. doi:
10.1016/j.neuropharm.2004.06.025
Frontiers in Neuroscience | www.frontiersin.org 20 February 2016 | Volume 10 | Article 13
Cadoni Modeling Genetic Vulnerability to Addiction
Rodgers, R. J., and Cole, J. C. (1993). Influence of social isolation, gender, strain,
and prior novelty on plus-maze behaviour in mice. Physiol. Behav. 54, 729–736.
doi: 10.1016/0031-9384(93)90084-S
Rodrigues, L. C., Gobira, P. H., de Oliveira, A. C., Pelição, R., Teixeira, A.
L., Moreira, F. A., et al. (2014). Neuroinflammation as a possible link
between cannabinoids and addiction. Acta Neuropsychiatr. 26, 334–346. doi:
10.1017/neu.2014.24
Rotzinger, S., and Vaccarino, F. J. (2003). Cholecystokinin receptor subtypes: role
in the modulation of anxiety-related and reward-related behaviours in animal
models. J. Psychiatry Neurosci. 28, 171–181.
Rougé-Pont, F., Marinelli, M., Le Moal, M., Simon, H., and Piazza, P. V.
(1995). Stress-induced sensitization and glucocorticoids. II. Sensitization of
the increase in extracellular dopamine induced by cocaine depends on stress-
induced corticosterone secretion. J. Neurosci. 15, 7189–7195.
Rutter, M., and Silberg, J. (2002). Gene-environment interplay in relation to
emotional and behavioral disturbance. Annu. Rev. Psychol. 53, 463–490. doi:
10.1146/annurev.psych.53.100901.135223
Saddoris, M. P., Sugam, J. A., Cacciapaglia, F., and Carelli, R. M. (2013). Rapid
dopamine dynamics in the accumbens core and shell: learning and action.
Front. Biosci. (Elite Ed) 5, 273–288. doi: 10.2741/E615
Sánchez-Cardoso, P., Higuera-Matas, A., Martín, S., del Olmo, N., Miguéns,
M., García-Lecumberri, C., et al. (2007). Modulation of the endogenous
opioid system after morphine self-administration and during its extinction:
a study in Lewis and Fischer 344 rats. Neuropharmacology 52, 931–948. doi:
10.1016/j.neuropharm.2006.10.011
Sánchez-Cardoso, P., Higuera-Matas, A., Martín, S., Miguéns, M., Del Olmo, N.,
García-Lecumberri, C., et al. (2009). Strain differences between Lewis and
Fischer 344 rats in the modulation of dopaminergic receptors after morphine
self-administration and during extinction. Neuropharmacology 57, 8–17. doi:
10.1016/j.neuropharm.2009.03.014
Sanchis-Segura, C., and Spanagel, R. (2006). Behavioural assessment of drug
reinforcement and addictive features in rodents: an overview. Addict. Biol. 11,
2–38. doi: 10.1111/j.1369-1600.2006.00012.x
Sarnyai, Z., Shaham, Y., and Heinrichs, S. C. (2001). The role of corticotropin-
releasing factor in drug addiction. Pharmacol. Rev. 53, 209–243.
Schumann, G. (2006). Hypothalamic-pituitary-adrenal axis and substance use:
so many questions–and we can answer them. Addiction 101, 1538–1539. doi:
10.1111/j.1360-0443.2006.01641.x
Selim, M., and Bradberry, C. W. (1996). Effect of ethanol on extracellular 5-HT
and glutamate in the nucleus accumbens and prefrontal cortex: comparison
between the Lewis and Fischer 344 rat strains. Brain Res. 716, 157–164. doi:
10.1016/0006-8993(95)01385-7
Selvas, A., Coria, S. M., Kastanauskaite, A., Fernaud-Espinosa, I., DeFelipe, J.,
Ambrosio, E., et al. (2015). Rat-strain dependent changes of dendritic and spine
morphology in the hippocampus after cocaine self-administration.Addict. Biol.
doi: 10.1111/adb.12294. [Epub ahead of print].
Seroogy, K., Schalling, M., Brené, S., Dagerlind, A., Chai, S. Y., Hökfelt, T.,
et al. (1989). Cholecystokinin and tyrosine hydroxylase messenger RNAs in
neurons of rat mesencephalon: peptide/monoamine coexistence studies using
in situ hybridization combined with immunocytochemistry. Exp. Brain. Res. 74,
149–162. doi: 10.1007/BF00248288
Sharp, B. M., Chen, H., Gong, S., Wu, X., Liu, Z., Hiler, K., et al. (2011). Gene
expression in accumbens GABA neurons from inbred rats with different
drug-taking behavior. Genes Brain Behav. 10, 778–788. doi: 10.1111/j.1601-
183X.2011.00716.x
Shoaib, M., Schindler, C. W., and Goldberg, S. R. (1997). Nicotine self-
administration in rats: strain and nicotine pre-exposure effects on acquisition.
Psychopharmacology 129, 35–43. doi: 10.1007/s002130050159
Shurin, M. R., Kusnecov, A.W., Riechman, S. E., and Rabin, B. S. (1995). Effect of a
conditioned aversive stimulus on the immune response in three strains of rats.
Psychoneuroendocrinology 20, 837–849. doi: 10.1016/0306-4530(95)00010-0
Silverman, M. N., and Sternberg, E. M. (2012). Glucocorticoid regulation of
inflammation and its functional correlates: from HPA axis to glucocorticoid
receptor dysfunction. Ann. N.Y. Acad. Sci. 1261, 55–63. doi: 10.1111/j.1749-
6632.2012.06633.x
Simar, M. R., Saphier, D., and Goeders, N. E. (1996). Differential neuroendocrine
and behavioral responses to cocaine in Lewis and Fischer rats.
Neuroendocrinology 63, 93–100. doi: 10.1159/000126940
Sinha, R. (2011). New findings on biological factors predicting addiction relapse
vulnerability.Curr. Psychiatry Rep. 13, 398–405. doi: 10.1007/s11920-011-0224-
0
Smith, C. C., Hauser, E., Renaud, N. K., Leff, A., Aksentijevich, S., Chrousos,
G. P., et al. (1992). Increased hypothalamic [3H]flunitrazepam binding in
hypothalamic-pituitary-adrenal axis hyporesponsive Lewis rats. Brain Res. 569,
295–299. doi: 10.1016/0006-8993(92)90642-M
Smith, C. C., Omeljaniuk, R. J., Whitfield, H. J. Jr., Aksentijevich, S., Fellows,
M. Q., Zelazowska, E., et al. (1994). Differential mineralocorticoid (type 1)
and glucocorticoid (type 2) receptor expression in Lewis and Fischer rats.
Neuroimmunomodulation 1, 66–73. doi: 10.1159/000097092
Solinas, M., Goldberg, S. R., and Piomelli, D. (2008). The endocannabinoid
system in brain reward processes. Br. J. Pharmacol. 154, 369–383. doi:
10.1038/bjp.2008.130
Spanagel, R., Herz, A., and Shippenberg, T. S. (1990). The effects of opioid peptides
on dopamine release in the nucleus accumbens: an in vivomicrodialysis study.
J. Neurochem. 55, 1734–1740. doi: 10.1111/j.1471-4159.1990.tb04963.x
Spiga, S., Mulas, G., Piras, F., and Diana, M. (2014). The “addicted” spine. Front.
Neuroanat. 8:110. doi: 10.3389/fnana.2014.00110
Spina, L., Fenu, S., Longoni, R., Rivas, E., and Di Chiara, G. (2006). Nicotine-
conditioned single-trial place preference: selective role of nucleus accumbens
shell dopamine D1 receptors in acquisition. Psychopharmacology 184, 447–455.
doi: 10.1007/s00213-005-0211-4
Stein, J. S., Pinkston, J. W., Brewer, A. T., Francisco, M. T., and Madden, G. J.
(2012). Delay discounting in Lewis and Fischer 344 rats: steady-state and rapid-
determination adjusting-amount procedures. J. Exp. Anal. Behav. 97, 305–321.
doi: 10.1901/jeab.2012.97-305
Stephens, D. N., Duka, T., Crombag, H. S., Cunningham, C. L., Heilig, M., and
Crabbe, J. C. (2010). Reward sensitivity: issues of measurement, and achieving
consilience between human and animal phenotypes. Addict. Biol. 15, 145–168.
doi: 10.1111/j.1369-1600.2009.00193.x
Sternberg, E. M., Glowa, J. R., Smith, M. A., Calogero, A. E., Listwak, S.
J., Aksentijevich, S., et al. (1992). Corticotropin releasing hormone related
behavioral and neuroendocrine responses to stress in Lewis and Fischer rats.
Brain Res. 570, 54–60. doi: 10.1016/0006-8993(92)90563-O
Stöhr, T., Schulte Wermeling, D., Weiner, I., and Feldon, J. (1998). Rat
strain differences in open-field behavior and the locomotor stimulating and
rewarding effects of amphetamine. Pharmacol. Biochem. Behav. 59, 813–818.
doi: 10.1016/S0091-3057(97)00542-X
Stöhr, T., Szuran, T., Welzl, H., Pliska, V., Feldon, J., and Pryce, C. R. (2000).
Lewis/Fischer rat strain differences in endocrine and behavioural responses
to environmental challenge. Pharmacol. Biochem. Behav. 67, 809–819. doi:
10.1016/S0091-3057(00)00426-3
Strecker, R. E., Eberle, W. F., and Ashby, C. R. Jr. (1995). Extracellular dopamine
and its metabolites in the nucleus accumbens of Fischer and Lewis rats: basal
levels and cocaine-induced changes. Life Sci. 56, PL135–PL141.
Suzuki, T., George, F. R., and Meisch, R. A. (1988a). Differential establishment
and maintenance of oral ethanol reinforced behavior in Lewis and Fischer 344
inbred rat strains. J. Pharmacol. Exp. Ther. 245, 164–170.
Suzuki, T., Koike, Y., Yanaura, S., George, F. R., and Meisch, R. A. (1987). Genetic
differences in the development of physical dependence on pentobarbital in
four inbred strains of rats. Jpn. J. Pharmacol. 45, 479–486. doi: 10.1254/jjp.
45.479
Suzuki, T., Lu, M. S., Motegi, H., Yoshii, T., and Misawa, M. (1992). Genetic
differences in the development of physical dependence upon diazepam in Lewis
and Fischer 344 inbred rat strains. Pharmacol. Biochem. Behav. 43, 387–393.
doi: 10.1016/0091-3057(92)90167-E
Suzuki, T., Otani, K., Koike, Y., and Misawa, M. (1988b). Genetic differences in
preferences for morphine and codeine in Lewis and Fischer 344 inbred rat
strains. Jpn. J. Pharmacol. 47, 425–431. doi: 10.1254/jjp.47.425
Sziraki, I., Lipovac, M. N., Hashim, A., Sershen, H., Allen, D., Cooper, T.,
et al. (2001). Differences in nicotine-induced dopamine release and nicotine
pharmacokinetics between Lewis and Fischer 344 rats. Neurochem. Res. 26,
609–617. doi: 10.1023/A:1010979018217
Tanda, G., Pontieri, F. E., and Di Chiara, G. (1997). Cannabinoid
and heroin activation of mesolimbic dopamine transmission by a
common mu1 opioid receptor mechanism. Science 276, 2048–2050. doi:
10.1126/science.276.5321.2048
Frontiers in Neuroscience | www.frontiersin.org 21 February 2016 | Volume 10 | Article 13
Cadoni Modeling Genetic Vulnerability to Addiction
Thanos, P. K., Volkow, N. D., Freimuth, P., Umegaki, H., Ikari, H., Roth,
G., et al. (2001). Overexpression of dopamine D2 receptors reduces
alcohol self-administration. J. Neurochem. 78, 1094–1103. doi: 10.1046/j.1471-
4159.2001.00492.x
Tomie, A., Aguado, A. S., Pohorecky, L. A., and Benjamin, D. (1998).
Ethanol induces impulsive-like responding in a delay-of-reward operant
choice procedure: impulsivity predicts autoshaping. Psychopharmacology 139,
376–382. doi: 10.1007/s002130050728
Tzschentke, T. M. (1998). Measuring reward with the conditioned place preference
paradigm: a comprehensive review of drug effects, recent progress and new
issues. Prog. Neurobiol. 56, 613–672. doi: 10.1016/S0301-0082(98)00060-4
Tzschentke, T. M. (2007). Measuring reward with the conditioned place preference
(CPP) paradigm: update of the last decade. Addict. Biol. 12, 227–462. doi:
10.1111/j.1369-1600.2007.00070.x
Tsuang, M. T., Bar, J. L., Stone,W. S., and Faraone, S. V. (2004). Gene-environment
interactions in mental disorders.World Psychiatry 3, 73–83.
Vanderschuren, L. J., and Kalivas, P. W. (2000). Alterations in dopaminergic
and glutamatergic transmission in the induction and expression of behavioral
sensitization: a critical review of preclinical studies. Psychopharmacology 151,
99–120. doi: 10.1007/s002130000493
van Leeuwen, A. P., Creemers, H. E., Greaves-Lord, K., Verhulst, F. C., Ormel,
J., and Huizink, A. C. (2011). Hypothalamic-pituitary-adrenal axis reactivity
to social stress and adolescent cannabis use: the TRAILS study. Addiction 106,
1484–1492. doi: 10.1111/j.1360-0443.2011.03448.x
Vink, J. M., Willemsen, G., and Boomsma, D. I. (2005). Heritability of
smoking initiation and nicotine dependence. Behav. Genet. 35, 397–406. doi:
10.1007/s10519-004-1327-8
Vinson, G. P., and Brennan, C. H. (2013). Addiction and the adrenal cortex.
Endocr. Connect. 2, R1–R14. doi: 10.1530/ec-13-0028
Voigt, M., Wang, R. Y., and Westfall, T. C. (1986). Cholecystokinin octapeptides
alter the release of endogenous dopamine from the rat nucleus accumbens
in vitro. J. Pharmacol. Exp. Ther. 237, 147–153.
Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Ding, Y. S., Sedler, M.,
et al. (2001). Low level of brain dopamine D2 receptors in methamphetamine
abusers: association with metabolism in the orbitofrontal cortex. Am. J.
Psychiatry 158, 2015–2021. doi: 10.1176/appi.ajp.158.12.2015
Volkow, N. D., Fowler, J. S., Wang, G. J., Hitzemann, R., Logan, J., Schlyer, D.
J., et al. (1993). Decreased dopamine D2 receptor availability is associated
with reduced frontal metabolism in cocaine abusers. Synapse 14, 169–177. doi:
10.1002/syn.890140210
Volkow, N. D., Wang, G. J., Begleiter, H., Porjesz, B., Fowler, J. S., Telang, F.,
et al. (2006). High levels of dopamine D2 receptors in unaffected members
of alcoholic families: possible protective factors. Arch. Gen. Psychiatry 63,
999–1008. doi: 10.1001/archpsyc.63.9.999
Volkow, N. D., Wang, G. J., Fowler, J. S., Logan, J., Hitzemann, R., Ding, Y. S.,
et al. (1996). Decreases in dopamine receptors but not in dopamine transporters
in alcoholics. Alcohol. Clin. Exp. Res. 20, 1594–1598. doi: 10.1111/j.1530-
0277.1996.tb05936.x
Volkow, N. D., Wang, G. J., Fowler, J. S., Thanos, P. P., Logan, J., Gatley, S. J.,
et al. (2002). Brain DA D2 receptors predict reinforcing effects of stimulants in
humans: replication study. Synapse 46, 79–82. doi: 10.1002/syn.10137
Wain, L. V., Shrine, N., Miller, S., Jackson, V. E., Ntalla, I., Artigas, M. S., et al.
(2015). Novel insights into the genetics of smoking behaviour, lung function,
and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association
study in UK Biobank. Lancet Respir. Med. 3, 769–781. doi: 10.1016/S2213-
2600(15)00283-0
Wang, H., and Lupica, C. R. (2014). Release of endogenous cannabinoids
from ventral tegmental area dopamine neurons and the modulation of
synaptic processes. Prog. Neuropsychopharmacol. Biol. Psychiatry 52, 24–27.
doi: 10.1016/j.pnpbp.2014.01.019
Wang, J., Yuan, W., and Li, M. D. (2011). Genes and pathways co-
associated with the exposure to multiple drugs of abuse, including alcohol,
amphetamine/methamphetamine, cocaine, marijuana, morphine, and/or
nicotine: a review of proteomics analyses. Mol. Neurobiol. 44, 269–286. doi:
10.1007/s12035-011-8202-4
Wang, J., Zhao, Z., Liang, Q., Wang, X., Chang, C., Wang, J., et al. (2008). The
nucleus accumbens core has a more important role in resisting reactivation
of extinguished conditioned place preference in morphine-addicted rats. J. Int.
Med. Res. 36, 673–681. doi: 10.1177/147323000803600408
Wang, R. Y., White, F. J., and Voigt, M. M. (1985). Interactions of cholecystokinin
and dopamine in the nucleus accumbens. Ann. N.Y. Acad. Sci. 448, 352–360.
doi: 10.1111/j.1749-6632.1985.tb29930.x
Wenzel, J. M., and Cheer, J. F. (2014). Endocannabinoid-dependent modulation
of phasic dopamine signaling encodes external and internal reward-predictive
cues. Front. Psychiatry 5:118. doi: 10.3389/fpsyt.2014.00118
Wilhelm, C. J., and Mitchell, S. H. (2009). Strain differences in delay discounting
using inbred rats. Genes Brain Behav. 8, 426–434. doi: 10.1111/j.1601-
183X.2009.00484.x
Windle, R. J., Wood, S. A., Lightman, S. L., and Ingram, C. D. (1998). The
pulsatile characteristics of hypothalamo-pituitary-adrenal activity in female
Lewis and Fischer 344 rats and its relationship to differential stress responses.
Endocrinology 139, 4044–4052. doi: 10.1210/en.139.10.4044
Winstanley, C. A., Olausson, P., Taylor, J. R., and Jentsch, J. D. (2010). Insight into
the relationship between impulsivity and substance abuse from studies using
animal models. Alcohol Clin. Exp. Res. 34, 1306–1318. doi: 10.1111/j.1530-
0277.2010.01215.x
Winstanley, C. A., Baunez, C., Theobald, D. E., and Robbins, T. W. (2005). Lesions
to the subthalamic nucleus decrease impulsive choice but impair autoshaping in
rats: the importance of the basal ganglia in Pavlovian conditioning and impulse
control. Eur. J. Neurosci. 21, 3107–3116. doi: 10.1111/j.1460-9568.2005.04143.x
Winstanley, C. A., Dalley, J. W., Theobald, D. E., and Robbins, T. W. (2004).
Fractionating impulsivity: contrasting effects of central 5-HT depletion
on different measures of impulsive behavior. Neuropsychopharmacology 29,
1331–1343. doi: 10.1038/sj.npp.1300434
Wise, R. A. (1996). Addictive drugs and brain stimulation reward. Annu. Rev.
Neurosci. 19, 319–340. doi: 10.1146/annurev.ne.19.030196.001535
Wise, R. A., and Koob, G. F. (2014). The development and maintenance of drug
addiction. Neuropsychopharmacology 39, 254–262. doi: 10.1038/npp.2013.261
Xiao, M. F., Xu, J. C., Tereshchenko, Y., Novak, D., Schachner, M., and Kleene, R.
(2009). Neural cell adhesion molecule modulates dopaminergic signaling and
behavior by regulating dopamine D2 receptor internalization. J. Neurosci. 29,
14752–14763. doi: 10.1523/JNEUROSCI.4860-09.2009
Yang, Q., and Khoury, M. J. (1997). Evolving methods in genetic epidemiology. III.
Gene-environment interaction in epidemiologic research. Epidemiol. Rev. 19,
33–43. doi: 10.1093/oxfordjournals.epirev.a017944
Zhao, C. J., Noack, C., Brackmann, M., Gloveli, T., Maelicke, A., Heinemann,
U., et al. (2009). Neuronal Ca2+ sensor VILIP-1 leads to the upregulation
of functional alpha4beta2 nicotinic acetylcholine receptors in hippocampal
neurons.Mol. Cell. Neurosci. 40, 280–292. doi: 10.1016/j.mcn.2008.11.001
Zhong, X., Drgonova, J., Li, C. Y., and Uhl, G. R. (2015). Human cell adhesion
molecules: annotated functional subtypes and overrepresentation of addiction-
associated genes. Ann. N.Y. Acad. Sci. 1349, 83–95. doi: 10.1111/nyas.12776
Zorrilla, E. P., Logrip, M. L., and Koob, G. F. (2014). Corticotropin releasing
factor: a key role in the neurobiology of addiction. Front. Neuroendocrinol. 35,
234–244. doi: 10.1016/j.yfrne.2014.01.001
Zubieta, J. K., Gorelick, D. A., Stauffer, R., Ravert, H. T., Dannals, R. F., and Frost,
J. J. (1996). Increased mu opioid receptor binding detected by PET in cocaine-
dependent men is associated with cocaine craving.Nat. Med. 2, 1225–1229. doi:
10.1038/nm1196-1225
Conflict of Interest Statement: The author declares that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Cadoni. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Neuroscience | www.frontiersin.org 22 February 2016 | Volume 10 | Article 13
